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Synopsis 
This thesis sheds light on the following areas in the investigation of overactive bladder: 
1. Update of the systematic review of the existing evidence on the role of bladder wall 
thickness (BWT) in the diagnosis of detrusor overactivity. 2. Accuracy of BWT in the 
diagnosis of detrusor overactivity. 3. Reproducibility of transvaginal BWT on ultrasound 
scan.4. A comparison of patient acceptability of both the diagnostic techniques-transvaginal 
BWT scan vs. urodynamics in women with overactive bladder. 
  
Based on the findings of this study, I recommend that BWT scan is not an accurate diagnostic 
test in diagnosing detrusor overactivity in women with overactive bladder. 
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Executive abstract 
Objectives 
This thesis has the following objectives: 
Primary:  
To estimate the accuracy of bladder wall thickness (BWT), measurement by transvaginal 
bladder ultrasound (BUS) in diagnosing detrusor overactivity (DO) 
Secondary: 
To generate pooled evidence on the role of BWT scan in diagnosing DO by an update of 
systematic review 
To assess whether measurements of BWT have adequate reliability and reproducibility  
To investigate the acceptability of BWT scan compared to urodynamics 
Methods 
A cross-sectional test accuracy study was undertaken to the estimate the accuracy of bladder 
wall thickness (BWT) in diagnosing DO in 687 women with overactive bladder (OAB) 
symptoms or urgency predominant mixed incontinence. Eligible women from 22 UK 
hospitals were recruited and BWT was measured using transvaginal ultrasound scans (index 
test). All women had the reference test of multichannel urodynamics, which was undertaken 
blind to the findings of the transvaginal ultrasound. The primary analysis involved 
calculations of sensitivity, specificity, predictive values and likelihood ratios using a BWT of 
5mm as a cut-off (>=5mm indicating presence of DO, <5mm indicating absence of DO). A 
receiver operator characteristics (ROC) curve was constructed and the area under the curve 
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computed (with 95% CI) to give an overall estimate of BWT accuracy across all thresholds of 
BWT. 
 
The intra- and inter-observer reproducibility of measuring BWT was assessed in three subsets 
of the transvaginal scans. For each subset, BWT measurements were analysed using one-way 
analysis of variance and the intra-class correlation and repeatability coefficients were derived. 
 
The acceptability of transvaginal BWT and urodynamics from the patient’s perspective was 
evaluated through the completion of self-reported questionnaires containing visual analogue 
scales for pain, levels of embarrassment, ordinal scales for acceptability and a generic state 
anxiety measure. Mean differences and 95% confidence intervals were determined by a 
paired t-test for pain and anxiety scores. Wilcoxon signed-rank test was used for acceptability 
responses and McNemar’s test for binary responses. 
Results 
Test accuracy & reproducibility studies 
The mean age of the 687 women consenting to the study was 52.7 years (SD 13.9) and the 
average BMI was 30.6 (SD 12.2). Fifty five percent (387/687) of the women were 
postmenopausal. According to the clinical history, 61% (419/687) had urgency predominant 
mixed incontinence and 33% (226/687) reported only urinary urgency along with increased 
frequency. The median duration of symptoms was 3.0 years (IQR: 1.6, 7.0). Six hundred and 
forty four participants had both the index and reference standard carried out. 
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Estimation of the accuracy of BWT showed poor sensitivity, specificity and likelihood ratios 
at all pre-specified cut-offs. The ROC curve showed no evidence of discrimination at any 
threshold between those with and without DO (p=0.25): the AUC was 0.53, 95%CI: (0.48, 
0.57). Furthermore, there was no evidence that the mean BWT measurements were any 
higher in the DO positive group compared with the DO negative group: 4.85mm (SD: 1.36) 
versus 4.70mm (SD: 1.29); p=0.19. Extensive sensitivity analyses and subgroup analyses did 
not alter these findings. 
 
For the intra-observer variation study, the individual variability in standard deviation (SD) 
was 1.04mm with an analytical variation of 0.42mm.In the inter-observer variation study on 
interpretation of stored images, we found an SD of 1.23mm with an analytical variation of 
0.35mm. In the prospective interobserver variation study of repeated scans performed by two 
independent observers, the SD was 0.95mm with an analytical variability of 0.76mm. 
Acceptability of tests 
Six hundred and forty-six (94%) participants in the study completed the acceptability 
questionnaire following both tests. Pain levels following both tests appeared relatively low, 
with scores during and shortly after urodynamics slightly higher than the corresponding 
scores during and after a BWT scan. There was a trend towards greater acceptability of BWT 
scan compared to urodynamics (p<0.001), (81% versus 56%). Fewer women felt that they 
would recommend urodynamics to a friend compared to a BWT scan (86% v 96%; p<0.001) 
and have the same test again (88% v 97%, p<0.001). Nearly 20% of women reported 
moderate levels of embarrassment with urodynamics compared to 10% with BWT scan 
(p<0.001). Both the tests appeared to provoke moderate levels of anxiety levels (12.6 for 
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BWT scan and 12.9 for urodynamics), although the scores were only slightly higher with 
urodynamics (0.3 points difference on a 4-24 scale, 95%CI: 0.1 to 0.5; p=0.02). 
Conclusion 
There was no evidence that transvaginal BWT had any relationship with DO, regardless of 
the cut-off point. Bladder wall thickness measurement did not discriminate women with DO 
versus those without DO and hence is not an accurate test for diagnosing DO. In the presence 
of high levels of analytical variation for the measurement of BWT, it is unlikely that BWT 
measurement made by transvaginal ultrasound has sufficient reliability and reproducibility to 
be a precise diagnostic test. Women experienced higher levels of embarrassment and a lower 
rate of acceptability with urodynamics compared to the BWT scan procedure. 
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Chapter 1: Introduction 
1.1 Background 
Urinary incontinence (UI) is defined by the International Continence Society as 'the 
complaint of any involuntary leakage of urine’. Urinary incontinence has a significant 
negative impact on the quality of life. Women affected by this condition find it 
psychologically distressing and socially restrictive. Urgency UI (involuntary leakage during 
or immediately preceeded by urgency), stress UI (involuntary urine leakage with physical 
activity or on sneezing or coughing), and mixed UI (a combination of the above two types) 
are the common types on incontinence (Haylen et al. 2010).  
1.2 Overactive bladder (OAB) 
International Continence Society (ICS)/International Urogynaecology Association defines 
overactive bladder(OAB) as a symptom complex of urinary urgency (intense, sudden desire 
to void) with or without incontinence, increased urinary frequency, or nocturia in the absence 
of infection or other proven pathology(Haylen, de, Freeman, Swift, Berghmans, Lee, Monga, 
Petri, Rizk, Sand, & Schaer 2010). Increased urinary frequency and urgency symptoms are 
more prevalent in patients with OAB than incontinence. Urgency incontinence which is the 
most distressing symptom of OAB, affects only a third of patients (Abrams 2003).  
 
Millions of people worldwide suffer from OAB. In the epiLUTS study, 12.8% of the 
population were found to suffer from OAB (Coyne et al. 2009). Prevalence and severity of 
OAB are known to increase with age. The prevalence seems to increase from 14.9% in the 
18-29yrs group, to 21.3% in the 30-39yrs group, 32.9% in the 40-49yrs group, 35.8% in the 
50-59yrs group and 39.8% in the 60-69yrs group (Coyne et al. 2013). It is anticipated that the 
20 
 
burden of OAB will increase with the increase in longevity, over the next few decades from 
500 million in 2013 to 546 million by 2018 (20.1% increase) (Irwin et al. 2011).  
 
OAB can have an enormous impact on the overall wellbeing of the affected women (Irwin et 
al. 2006). They tend to severely restrict their fluid intake to control urinary frequency and 
carry out ‘toilet mapping’ to cope with the feeling of urgency and urgency incontinence 
(Irwin, Milsom, Kopp, Abrams, & Cardozo 2006). The fear of coital incontinence may have a 
serious impact on their relationships (Jha et al. 2012). Low mood and depression due to social 
restriction and fear of embarrassment are reported more frequently in women with OAB. 
These symptoms may also result in significant financial implications (e.g. cost of pads, 
prescriptions, time off work, job losses, effects on the family etc.) (Freeman and Adekanmi 
2005). In the elderly population, nocturia secondary to urgency and urgency incontinence 
predisposes to falls and fractures (Mobley and Baum 2014). 
1.3 Mixed urinary incontinence 
The standardisation report ICS/IUGA describes mixed urinary incontinence (MUI) as a 
complaint of involuntary loss of urine associated with urgency and also with effort or 
physical exertion or on sneezing or coughing (Haylen, de, Freeman, Swift, Berghmans, Lee, 
Monga, Petri, Rizk, Sand, & Schaer 2010). MUI is the commonest form of UI. 
 
In a prevalence study on women complaining of lower urinary tract symptoms(LUTS), MUI 
with equal severity of urgency and stress was the commonest condition in 56%, stress 
predominant MUI in 29% and urgency predominant MUI in 15%. These prevalence rates on 
urodynamics changed to MUI with both stress incontinence (SUI) and detrusor overactivity 
(DO) in 18%, SUI in 42%, DO in 25% and normal findings in 15%. Urodynamic stress 
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incontinence was diagnosed in 82% of stress predominant MUI. In the urgency predominant 
MUI group, only 64% had DO on urodynamics (Digesu et al. 2003). 
 
Appropriate categorisation of women into urgency predominant or stress predominant MUI 
based on clinical history has been a matter of great debate. Medical, Epidemiological, and 
Social Aspects of Ageing (MESA) Questionnaire, urogenital distress inventory-urinary 
incontinence (UDI-UI) and visual analogue scale(VAS) scores for urgency component and 
stress component evaluation along with bladder dairies may be used to categorise women 
with mixed incontinence based on the predominant subcomponent (stress or 
urgency)(Brubaker et al. 2011). In busy clinical practice, however, women are categorised 
based on the symptoms they think are the most bothersome.  
1.4 Underlying pathology 
Detrusor overactivity (DO) is defined as the occurrence of involuntary detrusor contractions 
during filling cystometry. These contractions, which may be spontaneous or provoked, 
produce a wave form on the cystometrogram of variable duration and amplitude (Haylen, 
2010). Neurogenic detrusor overactivity is a condition where DO is demonstrated with 
evidence of a relevant neurological disorder (Haylen, 2010). DO may be the pathology 
behind OAB symptoms in 54-58% of people. The remaining 42-46% of the patients may 
have other pathologies causing OAB symptoms (Hashim and Abrams 2006)(Table 1). 
 
The pathophysiology of the OAB and DO are not yet understood completely. The following 
theories have been proposed: 
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a)The smooth muscle of the detrusor and the urothelium might generate increased afferent 
activity resulting in the symptoms of OAB (Andersson 2002).  
b)Spinal parasympathetic outflow is absent during the filling phase of the micturition cycle 
(de Groat 2006). Despite the absence of parasympathetic outflow, non-synchronized local 
contraction and relaxation might give rise to OAB symptoms (Andersson 2006). 
c) Cajal-like interstitial cells (ICC) may generate electrical potentials and stimulate detrusor 
contractions. The alterations in the transduction of the signals of ICCs between nerves and 
detrusor smooth muscle cells, along with alteration between afferent nerve endings and the 
urothelium (via suburothelial ICCs) may lead to a disturbance in spontaneous contractility 
resulting in DO (Juszczak 2014)(Kubota 2011).In vitro studies have shown that muscle strips 
from overactive bladder have increased spontaneous contractile activity than those from 
normal bladder (Kinder and Mundy 1987). 
d) Neuronal and non-neuronal sources release mediators to stimulate the detrusor myogenic 
contractile activity (Andersson and Wein 2004). Detrusor smooth muscle cells may become 
hyperexcitable, start reacting to minor stimuli resulting in untimely bladder contractions and 
give rise to the symptom of urgency (myogenic theory). The pathology may be purely 
intrinsic to the detrusor muscle (Darblade et al. 2006). 
 e) In normal bladder, there is a lack of coordination among various detrusor muscle units 
with some units contracting and others relaxing to stabilise intravesical pressure. Changes in 
intercellular communication may lead to an increased coordination between various units 
resulting in high amplitude contractions in patients with DO (Brading 1997). Other 
aetiological theories include failure of pelvic floor inhibitory reflexes during the filling phase 
and abnormalities in neurotransmission(Steers 2000). 
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Table 1: Conditions that cause overactive bladder 
 
Lower urinary tract conditions  Mechanism of effect 
Detrusor overactivity Involuntary detrusor contractions during 
filling/storage phase of the bladder 
Recurrent urinary tract infections 
 
 
Alterations in bladder mucosa may activate some 
pathways leading to irritative bladder symptoms 
Bladder outflow obstruction  
 
Detrusor hypertrophy secondary to obstruction may 
sometimes be iatrogenic(after a midurethral sling) 
Oestrogen deficiency 
 
Bladder mucosal atrophy, atrophic vaginitis and 
urethritis  
Neurological conditions: Multiple sclerosis, 
Cerebrovascular accidents, multi-infarct 
dementia, Parkinson’s disease, 
Space occupying lesions compressing the 
spine-benign or malignant 
Impairment of central inhibition of bladder causing 
causing neurogenic DO 
 
 
 
1.5 Evaluation of symptoms of OAB 
A detailed clinical history of urinary symptoms alone may not help in the identification of the 
underlying pathology (Jackson 1997;James et al. 1999). Clinical evaluation should include a 
3 day bladder diary of urinary habits (Smith et al. 2013) and a thorough clinical examination 
to rule out urogenital atrophy, any pelvic organ prolapse or any other urogenital 
abnormalities. The National Institute of Health and Care Excellence (NICE) guideline on 
urinary incontinence in women recommends conservative management as a first step in 
treatment. In women unresponsive to conservative management, the recommendation is to 
perform urodynamics to diagnose DO. NICE also recommends the incontinence-specific 
quality-of-life (QoL) scales in assessing the impact of urinary symptoms eg. ICIQ, UISS, 
ISI,BFLUTS, I-QOL, KHQ5, SEAPI-QMM, and SUIQQ (Smith, Bevan, Douglas, & James 
2013). 
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1.51 Clinical history  
Clinical history-taking for UI includes the type of incontinence, duration and severity of UI, 
impact on the quality of life, exacerbating factors like physical activity, quantity and quality 
of fluid intake and any medications, coexisting medical, surgical or gynaecological 
conditions. During the clinical assessment, the NICE recommends identification of other 
conditions where specialist input may be needed(Smith, Bevan, Douglas, & James 2013). In a 
literature review, sensitivity and specificity of clinical history compared to urodynamics was 
reported to be 0.69 and 0.60 for urgency incontinence/OAB, and 0.51 and 0.66 for women 
with MUI. Sensitivity for predicting DO in women with clinical symptoms of OAB was 0.76, 
but the specificity was only 0.57 (Colli et al. 2003). In a systematic review, sensitivity of 
clinical history for diagnosing DO was found to be 0.61 (0.57-0.65) and the specificity was 
0.87 (0.85-0.89). Approximately, 3-15% of women complaining of UI may have normal 
findings on urodynamics (Martin et al. 2006). Hence clinical history alone may not help in 
the identification of the underlying pathology. 
1.52 Bladder diaries in the assessment of OAB  
Bladder diaries may have diagnostic and prognostic value in the investigation and treatment 
of LUTS (Coyne, Sexton, Thompson, Milsom, Irwin, Kopp, Chapple, Kaplan, Tubaro, Aiyer, 
& Wein 2009). When the accuracy of bladder diaries in OAB patients against the urodynamic 
diagnosis of DO was evaluated, the sensitivity was found to be 0.88 and specificity 
0.83(Parsons et al. 2007).  
 
Data from the three day bladder diaries was found to be as accurate as those from the seven 
day diaries. Diaries of urinary habits collected over a three day period may improve the 
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accuracy of data collection by reducing the possibility of incorrect information from women 
who might complete some of the missing data from memory (Dmochowski et al. 2005). 
 
Severity of urinary urgency may be measured by urgency severity scores. Episodes of 
urgency, timing, activities predisposing to the sensation, the severity, the volume of leakage 
and the number of pads used are recorded (Chung et al. 2011).  
 
Women need to understand which predisposing factors make them leak and provide an 
accurate recording of diaries for their UI. Some patients might fill in only a part of the diary 
resulting in missing data. Other sources of inaccuracies/incomplete data may happen when 
women sometimes attempt to reconstruct their voiding habits from memory rather than fill 
their bladder diaries contemporaneously. 
1.53 Questionnaires 
1.531 ICIQ-OAB SF 
The International consultation on incontinence modular questionnaire-short form (ICIQ 
OAB-SF) allows a subjective measure of the severity of each component of OAB and its 
effect on QoL. The four scored items of the ICIQ-OAB are: Urinary frequency and its 
‘bother’ on visual analogue scale (VAS) ranging from 0 ‘‘Not at all’’ to 10 ‘‘A great deal’’, 
[2] nocturia and its ‘bother’ [3] urgency and its ‘bother’ and [4] urgency incontinence and its 
‘bother’. Shorter questionnaires are advantageous in settings, where the availability of time is 
limited. High ICIQ scores have a positive correlation with maximal detrusor pressure levels 
and low ICIQ scores have a negative correlation with the volume at the first sensation 
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(Seckiner et al. 2007). ICIQ-OAB SF questionnaire was used in the study as it was validated, 
short, simple and more likely to be completed by the patients. 
1.6 Urodynamic evaluation of OAB 
Urodynamics is a test used to assess the storage and voiding function of the bladder (Digesu 
et al. 2004). At present, laboratory urodynamics remains the gold standard test for assessment 
of LUTS (Coyne, Sexton, Thompson, Milsom, Irwin, Kopp, Chapple, Kaplan, Tubaro, Aiyer, 
& Wein 2009).Urodynamics consists of uroflowmetry and cystometry. Urodynamics done 
concomitantly with urethral pressure profile (UPP) may provide information about the 
detrusor contractility and urethral function along with the coordination between both (Digesu, 
Hutchings, Salvatore, Selvaggi, Milani, & Khullar 2004). 
  
In a Cochrane review, the role of urodynamics in the management of urinary incontinence 
has been questioned (Clement, 2013). Multichannel urodynamics have a 50–80% false 
negative rate compared to ambulatory urodynamics for diagnosing DO(Dokmeci et al. 2010). 
However, in asymptomatic women volunteers, ambulatory urodynamics seem to have a high 
false positive rate for DO (van Waalwijk van Doorn ES, 1992).  Due to the poor 
reproducibility of the findings during urodynamics, the bladder has been blamed to be an 
‘unreliable witness’(Hashim, 2006). In a study on women with a clinical history of pure SUI, 
a discordant finding of DO was found in 25% of the patients on urodynamics (Serati et al. 
2013). Inspite of all the above mentioned weaknesses, in the absence of a better diagnostic 
test, urodynamics was taken as the reference standard for the study. 
1.7 Bladder wall thickness  
Ultrasound scanning has been used in diagnosing bladder or urethral diverticula, the 
assessment of bladder neck in SUI and voiding dysfunction. Sonographic BWT has been 
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studied in various populations—women and children, and adult men with and without 
prostate hypertrophy. The technique was first described by Singer et al. in 1981(Singer D, 
1981).   
  
Normal BWT in adult women may range between 3–6 mm (Yang, 2002). The average BWT 
increased from 1.5mm to 2.76 mm in the paediatric age group to 3.0±1.0mm in adult women 
without LUTS. Bladder wall thickness had a small positive correlation with increasing age 
(Elbadawi et al. 1998). Increased interstitial collagen deposition may explain the small 
increase in BWT with age. With very small age related increase in the BWT, correction with 
respect to age may not be required (Hakenberg et al. 2000). 
 
Measurement of BWT may be useful in differentiating women with DO from those with SUI 
(Kuhn et al. 2011). In women with LUTS who show equivocal findings on urodynamics, 
BWT may prove to be a useful adjunctive test (Robinson, 2002).  
1.71 Technique and the route of scanning  
 
The bladder wall consists of the outer serosa, the detrusor muscle and the inner urothelium. 
On ultrasound scan of the bladder wall, the serosa and the urothelium have a hyperechoic 
appearance and the detrusor muscle, a hypoechoic appearance (Fig. 1). Bladder wall 
thickness is measured with the transvaginal probe in the sagittal plane introduced 1 cm 
beyond the vaginal introitus in the midline and the entire thickness of all the three layers 
measured. To measure the detrusor wall thickness (DWT) only, the hyperechoic urothelium 
and serosa are excluded from the measurement (Farag, 2011).  The echo-poor central area of 
the urethra is a useful landmark. Tangential measurements of BWT might erroneously 
suggest bladder-wall thickening, perpendicular imaging is recommended. When the probe is 
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perpendicular to the bladder wall, the hyperechoic layers of serosa and the urothelium appear 
as thin, distinct lines (Oelke, 2010 ). Measurements are to be made at maximum 
magnification. The BWT measurement is carried out in three sites-anterior wall, trigone and 
dome and an average BWT calculated. Bladder wall appearance/thickness is known to be 
fairly constant at small volumes of 0–50 ml (Khullar, 1994).  Figure 1 depicts the 
measurement of a normal bladder wall. 
Figure 1: Transvaginal scan of the normal bladder wall showing measurements of the trigone and 
parts of the dome 
 
 
With the transvaginal probe closest to the bladder, the margins of the bladder wall are more 
clearly visualised (Panayi, 2010). With transabdominal, introital (translabial) or perineal 
sonography, the probe is further away from the bladder and the resulting attenuation of 
ultrasound waves reduce the image quality.   
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1.72 Variations in the technique of BWT 
Transvaginal BWT measurement was first described by Khullar et al in the parasagittal plane. 
He measured the BWT at the trigone, dome and the anterior wall and calculated the average 
of the three measurements(Khullar, 1994). Some investigators measured only the dome 
thickness with the probe in the midline. The measurements were made in the sagittal plane at 
three different sites on the dome—midline and 1 cm on either side—and calculated mean 
BWT(Lekskulchai, 2008).  
1.73 Route of BWT scanning  
There has been much debate on the ideal route of bladder scanning-transvaginal, 
transperineal or transabdominal. We have chosen the transvaginal route of scanning for BWT 
due to the low interobserver difference, good quality images and the ease of the technique 
compared to transabdominal or translabial scanning(Panayi, 2010).  
1.74 Challenges in BWT measurement 
Transvaginal probes with high-frequency (e.g.>7 MHz) have a resolution of <0.13 mm and 
are ideal for measuring thin-walled structures like BWT. Appropriate gain settings and the 
focal zone adjustments are needed to ensure good visualisation of bladder wall. The 
uterovesical peritoneal reflection on to the dome of the bladder may add 1 mm to the BWT 
measurement (Jequier, 1987). Care should be taken not to include the vaginal wall while 
measuring BWT at the trigone. Visualising and measuring anterior wall thickness can be 
challenging in patients with cystocele and those who have undergone bladder-neck surgery. 
The bladder wall may be irregular and undulating and the outline of the margins may not be 
seen clearly. Sometimes the BWT may not be visualised perpendicularly depending on how 
the surrounding structures are indenting the bladder erroneously increasing the 
BWT(Rachaneni, 2013). Thickened urothelium (secondary to infection, catheterisation) may 
give a false positive thickened bladder wall measurement.  
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The demarcation of the different layers of bladder wall may be seen only when the probe is 
exactly perpendicular to the bladder wall. With the bladder being a curvilinear organ, the 
differentiation of all the three layers with transvaginal probe may be possible only at the 
trigone and not on the anterior wall and dome. On transabdominal scan, the demarcation of 
three layers may be possible for the anterior wall and not from the dome or trigone. 
1.75 Bladder wall thickening in LUTS-Possible clinical applications 
Overactive and obstructed bladders may be distinguishable from other LUTS by measuring 
BWT. In OAB patients, repeated detrusor contractions may give rise to the perception of 
urgency during the filling phase of micturition cycle. In response to the symptom of urgency 
and the fear of leakage, women may be voluntary activate the urethral sphincter and the 
pelvic floor musculature to increase the urethral closure pressure. These detrusor contractions 
against a closed urethral sphincter may result in the bladder wall thickening or hypertrophy 
(Khullar et al. 1996) (Serati et al. 2011).Bladder outflow obstruction may also result in 
detrusor hypertrophy(Harrison et al. 1987). Women who have an over corrected of bladder 
neck angle following SUI surgery may also show thickened bladder walls(Martan et al. 
2001). 
 
The study by Panayi et al. found that women with a mean BWT >5 mm had a significant 
increase in urinary frequency and higher visual analogue score for urgency compared with 
those with a mean BWT of <5 mm (Panayi, 2010). In a systematic review on the diagnostic 
accuracy of BWT scanning, for a 5-mm cut off, the sensitivity in diagnosing DO ranged from 
37 % to 84 % and specificity from 78 % to 89 % (Latthe, 2010 ).  Using 6 mm as cut off, 
Robinson et al. calculated a sensitivity of 22 % and specificity of 89 % for BWT as a marker 
for DO on ambulatory urodynamics (Robinson, 2002). As the cut-off increased to 6.5 mm in 
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another study, sensitivity was 13.3 %, specificity increased to 97.7 %, with a positive 
predictive value of 71.4 % and a negative predictive value of 72.1 % (Serati, 2010).  
 
Women with a previous history of paediatric nocturnal enuresis (enuresis after school entry) 
had thicker bladder walls with an average detrusor wall thickness (thickness of bladder wall 
after excluding the measurement of mucosa and the serosa) of 4.7(SD 2.1, range 2.1–10.6) 
mm compared to 4.2 (SD 1.7, range 1.5–14.2) mm in the non-nocturnal enuresis group 
(Lekskulchai O and Dietz 2006). In a pediatric study on the treatment with Desmopressin in 
children with nocturnal enuresis, response was poorer in children who had thickened bladder 
walls and reduced bladder capacity (Yeung, Eschenbacher, & Pauls 2014). 
 
In women complaining of DO and coital incontinence at orgasm, the bladder wall was found 
to be thicker compared to women with only DO (5.8 +/- 0.6 mm vs. 5.2 +/- 1.2 mm 
[P=0.007]) (Serati, Cattoni, Braga, Siesto, & Salvatore 2011). 
 
A significant correlation between BWT and detrusor pressure at maximum flow rate (p det/Q 
max values) was seen in a small study(Kuhn, 2011).  Bladder wall thickness measurement 
may be a promising technique to diagnose bladder outflow obstruction (BOO) that have the 
potential to replace urodynamics  needing further evaluation(Belal, 2006). 
 
Women with higher grades of uterovaginal prolapse may have a significant distortion of 
anatomy of anterior compartment and a relative urethral kink. The resulting infravesical 
obstruction may thicken the bladder wall(Farag, 2011) . However, in a retrospective study in 
patients with voiding dysfunction, there was no increase in mean BWT (Lekskulchai, 2009).  
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So far the role of thickened bladder wall in identifying the above mentioned conditions has 
been evaluated in studies which were lacking in methodological quality and hence no firm 
conclusions can be drawn.  
1.8 Acceptability of diagnostic tests-BWT and Urodynamics 
A diagnostic test is of no use in clinical practice if it is not generally acceptable to the 
population it is being offered to. Our index test was BWT measured on transvaginal scan. 
Transvaginal ultrasound scan is often used in gynaecological investigations. Transvaginal 
ultrasound scan has become an acceptable investigation among pregnant as well as non-
pregnant women across various ethnicities (Atalabi et al. 2012;Rosati and Guariglia 2000). 
 
In a study on patient experience of invasive diagnostic procedures, a third of pregnant women 
undergoing transvaginal scan experience mild pain or discomfort. Very few women described 
the experience as ‘excruciating’, ‘horrible’ or ‘distressing’. On a scale from 0 to 5, the 
measured perception of difficulty was rated as 1.3. When compared to other procedures 
which are perceived as uncomfortable or painful, women felt that transvaginal scan fared 
better than having a dental filling, a cervical smear or having a blood sample taken. However, 
they felt it was more discomforting than abdominal scan(Clement et al. 2003).  
 
Urodynamic test involves inserting a catheter into the bladder and another into the 
rectum/vagina. Pain, embarrassment and distress are reported by women undergoing 
urodynamics because of the invasive nature of the intervention(Yeung et al. 2014).Women 
with younger age, history of anxiety or depression, and a diagnosis of OAB and painful 
bladder syndrome have been reported to have more negative experiences during urodynamics 
(Yeung, Eschenbacher, & Pauls 2014). Currently, there are no published validated 
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questionnaires on the acceptability of urodynamics. To test the acceptability of  urodynamics 
and BWT testing, a questionnaire was constructed using validated instruments like visual 
analogue scale(VAS) measurements on pain during and after the test (Hjermstad et al. 2011), 
levels of embarrassment a person experienced, recommendation of the test to a friend and 
whether they were willing to go through the same test again (NHS Friends and Family test 
2012). 
1.81 STAI scores 
The State-Trait Anxiety Inventory (STAI) is a tool designed to differentiate and measure 
anxiety as a state and as a trait. The stable traits of an individual like calmness, confidence 
and anxiety proneness are measured on Trait anxiety scale (T-Anxiety). State Anxiety Scale 
is designed to measure the anxiety a person is experiencing at the time of evaluation. It also 
measures temporary changes in anxiety in response to a particular situation like worry 
apprehension, tension and nervousness. People who are more anxiety prone (higher T-
Anxiety scores) have a lower threshold of perception of danger or a threat. State anxiety 
scores are directly proportional to their trait anxiety scores (Spielberger 1983). State-Trait 
Anxiety Inventory-Short form (STAI-SF) questions were included in the acceptability 
questionnaire to study and compare the anxiety provoked by the index test and the reference 
standard. 
1.9 Rationale for the study 
The only investigation extensively used for investigation of LUTS is urodynamics. 
Urodynamics is an invasive, expensive investigation which is poorly tolerated and has a 
higher risk of urinary tract infections (Foon et al. 2012). A search for an alternative 
diagnostic test without the above mentioned weaknesses of urodynamics has identified 
thickened bladder wall as a possible marker for DO in a few observational studies(Khullar, 
1994) (Kuhn, 2011) . Bladder wall thickness scan by transvaginal route is less invasive, less 
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embarrassing, less uncomfortable and better tolerated test and it does not carry any risk of 
urinary infection. A systematic review of studies on the diagnostic accuracy of BWT has 
shown that there is absence of good quality evidence and there exists an equipoise on the 
clinical utility of BWT scan in diagnosing DO(Latthe et al. 2010). The technique and sites of 
BWT measurement has not been standardised with some studies measuring DWT 
(Lekskulchai, 2008) and some BWT (Khullar, 1994). The site of measurement of BWT was 
variable with some taking multiple measurements of the bladder dome (Lekskulchai, 2008) 
and some measuring it in three different sites-dome, anterior wall and trigone (Robinson, 
2002). There is a lack of consensus on the appropriate cut off required to make a diagnosis of 
DO (Latthe, 2010). 
 
Determining the accuracy of BWT is an essential first step in establishing its clinical 
effectiveness. If BWT scan proves to be an accurate test for diagnosing DO compared to 
urodynamics, it can replace urodynamics and improve patient experience in diagnostic 
workup, reduce the risk of urinary infection and hence my question of interest. Optimum 
BWT cut-off value for diagnosing various LUTS may then be standardised. A subsequent 
health economic evaluation may show the cost savings to the health care systems by 
replacing urodynamics with the less expensive BWT scan. Whether BWT scanning will help 
in the understanding of disease development, progression and prediction of response to 
treatment needs to be explored. The present study was designed to elicit the diagnostic 
accuracy of BWT in diagnosing DO.  
1.91 Aims and Objectives of the study  
The primary aim of this study was to evaluate whether BWT measurement has sufficient 
accuracy to reduce the need for urodynamics in the diagnosis of DO.  
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The secondary aims were to investigate the relative acceptability of urodynamics and BWT 
scan and to examine the reproducibility of BWT.   
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Chapter 2: Update of the systematic review on the accuracy of BWT as a 
biomarker in the diagnosis of detrusor overactivity 
Introduction 
The search for more reliable, less invasive simple and cost-effective tests as alternatives to 
urodynamics has led to the exploration of bladder wall thickness (BWT) scan as an 
alternative diagnostic technique. Detrusor muscle of the bladder may hypertrophy in response 
to increased workload of frequent involuntary contractions which are the hallmark of DO 
(Khullar et al. 1994). The hypertrophied detrusor may be visualized as thickened bladder wall 
on ultrasound scan. A systematic review was carried out in 2010 on the accuracy of BWT on 
transvaginal scan in the diagnosis of DO showed a trend towards increased BWT in women 
with DO(Latthe, Champaneria, & Khan 2010). In order to know whether there is any recent 
robust evidence on the diagnostic accuracy of BWT and to inform whether BWT can be used 
as an alternative to urodynamic diagnosis of DO, a comprehensive update of systematic 
review was carried out. 
2.1Evidence for the Accuracy of Bladder Ultrasound as a test for diagnosing DO 
An update of the systematic review of test accuracy studies on women who had an ultrasound 
scan to measure bladder wall thickness (BWT) against the reference standard of urodynamics 
to confirm DO was performed.  
2.2 Methods 
After formulating a protocol a priori using recommended methods (Khan et al. 2001), we carried out a 
systematic review by independent observers (SR and PL). A meta-analysis was performed using Rev 
Man 5.3 software and pooled estimates of test accuracy were calculated. 
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2.3 Search strategy 
Electronic searches were conducted in Medline, MEDION, EMBASE, LILACS, CINAHL 
and websites for abstracts from the annual meetings of ICS, IUGA, UKCS, EUA, AUGS 
from database inception to March 2015. We also carried out hand searches from the reference 
list of published articles. We used combinations of MeSH subheadings and key words. Our 
key words included ‘ultrasound’, ‘bladder’, ‘bladder wall thickness’, ‘detrusor wall 
thickness’, ‘overactive bladder’ and ‘detrusor overactivity’. We adapted a search strategy for 
each database and restricted our searches to studies on ‘women’. We did not apply any 
language restrictions or methodological filters, as this might lead to the omission of relevant 
papers. 
2.31 Identification of studies and data extraction 
Study selection was undertaken by electronic searches without any language restrictions. 
Selected studies were thoroughly scrutinized and the manuscripts of all the citations were 
obtained for a critical review. The four part question was: 
1. Population: Adults with urinary urgency, with or without frequency, nocturia and urgency 
incontinence 
2. Index Test: Bladder or detrusor wall thickness  
3. Reference standard: Urodynamic (laboratory and/or ambulatory) observation of DO 
4. Study design: All studies in which patients had undergone both the index test (ultrasound 
scan for bladder wall or detrusor wall thickness and reference standard, urodynamics 
SR and PL independently scrutinised all of the manuscripts to determine if they met the 
above criteria. Data on study characteristics, quality and results was extracted onto a data 
collection proforma. Data were also extracted on patient characteristics, methods of 
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recruitment and the procedural details of the two diagnostic tests- ultrasound and 
urodynamics. Any disagreements between the two reviewers on the inclusion/exclusion of a 
manuscript or on the extracted data were resolved by consensus. We have tried to contact the 
primary authors for missing data or additional data but there was no response. 
2.32 Methodological quality assessment  
We assessed the robustness of the methodology of the included manuscripts using the 
QUADAS checklist (Whiting et al. 2003). We looked at the appropriateness of the study 
design, relevant features of the study population, conduct of the index test and the reference 
standard of each study. We considered the study to be of good quality if it satisfied the 
QUADAS criteria. We have assessed the risk of bias in the included studies based on the 
criteria from Cochrane handbook for diagnostic test accuracy reviews.  
2.33 Data Synthesis 
To summarize sensitivity and specificity data for BWT, we constructed a Forest plot from the 
2x2 contingency tables cross-classifying index (BWT) test results and the reference standard 
(urodynamic diagnoses) using the Rev Man 5.3 software(Figure 5). For the meta-analysis, we 
have used the hierarchical summary receiver operating characteristic (HSROC) model to 
accommodate the limitations (paucity of robust data). As we were unsure whether the 
diagnostic accuracy was related to BWT threshold, we used allowances for asymmetry of the 
HSROC curve where the β≠0.We have calculated the pooled sensitivity, the specificity of the 
collated results of the studies included in the systematic review from the summary point of 
the SROC curve. 
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Figure 2: Flow chart for the selection of studies included in the update of systematic review of the 
accuracy of bladder wall thickness in detrusor overactivity 
 
 
 
2.4 Results 
Figure 2 summarises the process of systematic search and of study selection. A total of 54 
relevant studies were identified. Out of the 54 articles, 21 studies (18 prospective and 3 
retrospective) satisfied our inclusion criteria for the systematic review. The studies on 
pooling had 4151 women. Ten of the these 21 studies were case control in design( (Abou-
Gamrah et al. 2014;Chung et al. 2010;Ibrahim S and Najdy M 2011;Kuo 2009;Minardi et al. 
2007;Otsuki E N et al. 2014;Ozturk H et al. 2011;Parsons, Amundsen, Cardozo, Vella, 
Webster, & Coats 2007;Soligo M et al. 2002;Yang and Huang 2002) 
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Figure 3: Quality of studies included in the update of systematic review of the accuracy BWT in the 
diagnosis of DO 
 (stacked bar chart used with numbers inside bars indicate the number of studies) 
 
Transabdominal ultrasound was used in six studies at different bladder volumes to measure 
detrusor wall thickness (DWT)(Blatt et al. 2008;Chan L et al. 2005;Chung, Chiu, Kuo, 
Chuang, Wang, Guan, & Chancellor 2010;Kuo 2009;Ozturk H, Aydur E, Irkilata H, Seckin 
B, & Dayanc M 2011;Silva et al. 2014)(Tables 3 and 4) There was increased DWT(0.75mm) 
on transabdominal scan when measured at maximum capacity in women with DO with a 
sensitivity (73%) specificity (67%).and an AUC(0.776). However, women with DO had a 
lower bladder capacity compared to women without DO and no correction was employed to 
accommodate this variation (Kuo 2009). In other studies on transabdominal BWT, no such 
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increase was found at bladder capacity and at the first sensation of void (Chan L, The S, Tse 
V, & Titus J 2005).  
 
Twelve studies suggested that BWT may be useful to diagnose DO, although the reported 
sensitivity/specificity/area under the curve(AUC) varied amongst the studies (Tables 3 and 4) 
(Ibrahim S & Najdy M 2011;Khullar, Salvatore, Cardozo, Bourne, Abbott, & Kelleher 
1994;Khullar, Cardozo, Salvatore, & Hill 1996;Kuhn, Genoud, Robinson, Herrmann, 
Gunthert, Brandner, & Raio 2011;Minardi, Piloni, Amadi, El, Milanese, & Muzzonigro 
2007;Otsuki E N, Júnior E A, Oliveira E, Castelo Girão M J B, & Jármy-Di Bella Z I K 
2014;Ozturk H, Aydur E, Irkilata H, Seckin B, & Dayanc M 2011;Parsons, Amundsen, 
Cardozo, Vella, Webster, & Coats 2007;Robinson et al. 2002;Serati et al. 2010). Of these, 
five were prospective cohort studies and seven were case control studies. BWT was found to 
be increased in women with DO when compared to BWT with in patients with other types of 
incontinence in the above mentioned studies.  
 
In the study by Khullar et al, 42 women who had BWT of > 5mm and 4 women who had 
BWT of <3.5mm and did not have DO on urodynamics were further subjected to a secondary 
diagnostic test-the ambulatory urodynamics. Of these 36 women were diagnosed to have DO. 
So, 25% of the study participants had two reference standard tests leading to differential 
verification bias (Khullar, Cardozo, Salvatore, & Hill 1996)(Table 2). 
  
In another study by Robinson et al, the patients included were 128 women with OAB who did 
not have DO on conventional urodynamics and were subjected to ambulatory urodynamics 
which is a different reference standard. Hence this group is not representative of the standard 
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OAB population. The BWT was studied as a secondary diagnostic test rather than a primary 
index test and so the results of this study may not be applicable in routine clinical 
practice(Robinson, Anders, Cardozo, Bidmead, Toozs-Hobson, & Khullar 2002)(Table 2). 
 
On review of test accuracy data, the sensitivity ranged from 40-90.6% and specificity from 
78-96.6% for a mean BWT of 5 mm (Abou-Gamrah, Fawzy, Sammour, & Tadros 
2014;Khullar, Cardozo, Salvatore, & Hill 1996;Kuhn, Genoud, Robinson, Herrmann, 
Gunthert, Brandner, & Raio 2011)(Table 4).  
 
Only 7/21 studies reported on construction of the ROC curves (Abou-Gamrah, Fawzy, 
Sammour, & Tadros 2014;Ibrahim S & Najdy M 2011;Kuhn, Genoud, Robinson, Herrmann, 
Gunthert, Brandner, & Raio 2011;Kuo 2009;Lekskulchai & Dietz 2008;Serati, Salvatore, 
Cattoni, Soligo, Cromi, & Ghezzi 2010;Serati, Cattoni, Siesto, Braga, Sorice, Cantaluppi, 
Cromi, Ghezzi, Vitobello, Bolis, & Salvatore 2013). In a study by Kuhn et al, the ROC curve 
was used to predict forms of urinary incontinence and to demonstrate the relationship 
between SUI, OAB and obstructed outflow rather than to predict the diagnostic accuracy in 
each of the different urodynamic diagnoses. In the other six studies with the ROC curves, the 
AUC ranged from 0.606 to 0.776 (Table 4).  
 
On quality assessment based on QUADAS checklist, there was a significant variation across 
the studies (see figure 3). The route and the technique of performing the BWT scan, the 
urodynamic tests, (video-urodynamics, laboratory urodynamics and a combination of 
laboratory and ambulatory urodynamics), were highly variable across the studies. On risk of 
bias assessment, 18/21 studies were found to be ‘high in concern’ (Figure 4). 
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Figure 4: Risk of bias assessment 
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Visual inspection of forest plot has shown a significant variation of sensitivities and 
specificities was found for individual studies (Figure 5).  
Figure 5: Forest plot of sensitivities and specificities for BWT in diagnosing DO 
 
Using the Rev Man 5.3 software, I have constructed a HSROC curve. Each of the included 
studies in the meta-analysis is represented by a star on the HSROC curve.The size of the each 
star has varied according to the sample size of the study.The solid dot on the HSROC graph is 
the summary point estimate of sensitivity and specificity of studies included in the meta-
analyses. The summary point has given a pooled estimate of sensitivity of 66% and 
specificity of 38% on SROC curve (Figure 6) 
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Figure 6: Hierarchical SROC curve of test accuracy data from meta-analysis on diagnostic accuracy 
of BWT in diagnosing DO 
 
2.5 Discussion  
2.51Main findings 
The pooled estimates of sensitivity and specificity suggest questionable the reliability of 
BWT as a diagnostic test for OAB patients. The studies suffer from significant design flaws like 
underpowered and insufficient or inaccurate statistical evaluation.  
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2.52 Strengths & weaknesses  
The strengths of this review include a thorough and systematic search using the 
recommended methods and a predesigned protocol. The study selection and extraction of the 
data was carried out by two reviewers independently. We attempted to include the grey 
literature to reduce the risk of publication bias. Of the 21 studies which fulfilled our inclusion 
criteria, six of them have been conference abstracts and 15 were published articles. We have 
assessed the quality of the included studies using the QUADAS checklist (Figure 3) and the 
risk of bias (Figure 4) based on the criteria laid out by the Cochrane handbook for systematic 
reviews for diagnostic test accuracy. 
 
Small case-control/cohort studies on BWT in diagnosing DO seem to have erroneously 
amplified the effectiveness of BWT as a diagnostic marker of DO (Lijmer et al. 1999).Nearly 
half of the studies(10/21) included were case control in design(Tables 2 and 3). None of the 
studies were adequately powered to study the diagnostic accuracy of BWT in DO. The 
inclusion/exclusion criteria were not stringent enough to exclude the confounding factors. 
One study included a significant number of women with previous stress incontinence surgery 
who developed OAB symptoms. Inclusion of patients with iatrogenic partial bladder outflow 
obstruction which is an independent risk factor for bladder wall thickening might have altered 
the results of this study (Kuhn, Genoud, Robinson, Herrmann, Gunthert, Brandner, & Raio 
2011). 
 
Included studies showed significant heterogeneity in the site and route of BWT and also in 
the reference standards used. The techniques of measurement-BWT(full thickness of the 
bladder wall) or DWT(thickness of only the detrusor excluding the serosa and mucosa of the 
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bladder), sites of measurement(tables 2 and 3) (only dome thickness compared to that of an 
average BWT measurement were variable across different studies (Khullar, Salvatore, 
Cardozo, Bourne, Abbott, & Kelleher 1994;Robinson, Anders, Cardozo, Bidmead, Toozs-
Hobson, & Khullar 2002) (Lekskulchai and Dietz 2008). Each of these techniques have their 
own weaknesses and so far have not been standardised (Fransisco Cruz et al. 2009).  
 
The statistical evaluation in the studies ranged from point estimates of sensitivity, specificity, 
positive and negative predictive values to construction of ROC curves and the estimation of 
AUC. Thirteen of the included studies estimated mean BWT/DWT in the group with DO and 
compared it with those without DO. Their inaccurate study design and the methodology flaws 
were reflected in poor data presentation. Consequently 13/21 studies could not be included in 
the meta-analysis. Only 8 studies were included in the meta-analysis and these studies have 
exhibited significant inter-study heterogeneity with regards to study design, technique and 
route of BWT, cut off of BWT used and their sample sizes. Hence the results of meta-
analysis should be interpreted with caution.  
2.53 Interpretation of findings and conclusion 
All of the studies have significant methodological flaws which might have had an impact on 
the results questioning the usefulness of BWT as a diagnostic marker of DO. The pooled 
estimates indicative of low sensitivity and specificity from the SROC curve on the diagnostic 
accuracy of BWT could be due to the poor performance of the test itself or due to other 
factors like inappropriate study design, inadequate sample size and variable techniques and 
cut-offs of BWT used. No firm conclusion could be drawn from the systematic review due to 
the poor quality of the included studies. An appropriately designed, sufficiently powered 
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diagnostic accuracy study is needed to estimate the role of BWT and hence the BUS study 
was planned.  
Table 2: Characteristics of the included studies in the update of the systematic review of accuracy of 
transvaginal/ translabial bladder / detrusor wall thickness in detrusor overactivity 
Study, date, 
country, design 
Population Test Reference Standard 
Otsuki et al, 
2014,Brazil, 
prospective case 
control study 
n=91 women 
Cases:30 with DO 
Controls:31 with no incontinence and 30 
with SUI  
Transvaginal BWT 
measurements in the parasagittal 
plane at anterior wall, trigone 
and dome 
Urodynamics only in 
cases –DO and SUI. 
Controls did not undergo 
urodynamics. 
Abou-Gamrah  
et al,2014, Egypt, 
Prospective 
?Case control 
study 
Sample size calculation: 41 women in 
each of the two groups to detect a 
difference of 1 mm in mean BWT 
between both groups with a standard 
deviation (SD) of 1.6 with power of 80 
% and alpha error 0.05.  
DO=50 women 
USI=50 women 
Transvaginal ultrasound at a 
postvoid residual (PVR) of 
<50ml by an operator who was 
blind to urodynamics result.  
BWT at three sites: thickest part 
of the dome, the trigone, and the 
anterior wall.  
Urodynamics  performed 
as per ICS guidelines 
Kuhn et al, 
2011,UK, 
Prospective 
Cohort study 
 
122 women: 
Previous incontinence surgery=39, 
SUI=59, 
DO=40, Obstruction =24 
Transvaginal BWT was 
performed in all women at 
PVR<50ml. Technique not 
described. 
Clinician measuring BWT was 
blinded to urodynamics. 
Urodynamics performed 
in all women 
Ibrahim 
et.al,2011.UK, 
Egypt 
Prospective case 
control 
study(Conference 
abstract) 
60 women  
Detrusor instability=30   Healthy 
controls=30 
Transvaginal BWT was 
performed at <50ml at the 
trigone, dome and anterior wall. 
Clinician measuring BWT was 
blinded to the urodynamics 
result 
Urodynamics was 
performed only in cases. 
The authors do not seem 
to make a distinction 
between detrusor 
instability and OAB. 
Panayi. et 
al,2010,UK 
Prospective 
(Conference 
abstract) 
182 women underwent  both 
urodynamics and transvaginal BWT scan 
BWT was measured at trigone, 
dome and anterior wall  
All the participants 
underwent urodynamics 
Serati. et al 2010 247 women  All the study participants had 
urodynamics and transvaginal 
Urodynamics in all 
women according to 
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Italy, Prospective 
Cohort 
BWT ultrasound scans by the 
technique described by Khullar 
et al.  
BWT scan operator was blinded 
to urodynamics result. 
Good Urodynamics 
Practice guidelines of the 
ICS 
Lekskulchai et al 
2008  
Australia 
Retrospective 
cohort 
686 women underwent  multichannel  
urodynamics and translabial ultrasound  
Translabial ultrasound for DWT 
measurement(the iso-to hypo-
echogenic layer at the bladder 
dome opposite the internal 
urethral meatus and two 
additional measurements within 
2 cm of the mid-sagittal plane) 
Multi-channel  
urodynamics confirmed 
to ICS standards  
Minardi et al 
2007  
Italy 
Prospective 
Case-Control 
80 women- 
66 cases with  
SUI=36  
Urgency  incontinence=30  Controls=14  
DWT was measured at bladder 
dome Unsure whether 
translabial or introital 
ultrasound was used for DWT 
measurement. 
Urodynamics according 
to ICS criteria 
Parsons et al, 
2005,UK 
Prospective case 
control 
(Conference 
abstract) 
250 women: 
 
Cases=194,  
Women with DO=31 
Controls=61 
Withdrawals=26 
Transvaginal BWT at trigone, 
dome and anterior wall. 
Video urodynamics in all 
women 
31 women (18.5%) had 
DO 
Yang et al 2003  
Taiwan 
Retrospective 
492 women with LUTS who had 
undergone BWT and urodynamics and 
who had normal urinalysis findings, 
negative urine culture results, or both.  
DO=38, SUI=248,  MUI=39 
Hypersensitive bladder=35 
BWT at dome or trigone using 
transvaginal ultrasound  
Urodynamics at a filling 
rate of 80 ml/min with 
patient sitting upright in 
a birthing chair. 
Yang et al 
2002, 
Taiwan, 
Retrospective 
case control 
1049 women- SUI=764,  
Detrusor instability=190, Hypersensitive 
bladder=95. Controls=36 
BWT at dome or trigone using 
transvaginal ultrasound  
Urodynamics= 
uroflowmetry, filling and 
voiding phase 
cystometry, a urethral 
pressure profile at both 
resting and at valsalva.  
Detrusor instability was 
diagnosed if there was a 
detrusor contraction in 
association with urgency, 
leakage, or both 
Soligo et al, 
2002, 
Italy and UK 
Prospective case 
control study 
(Conference 
161 women-  OAB=70 
Normal controls=91.  
Detrusor instability=24 
Sites of BWT measurement not 
elaborated 
Urodynamics performed 
in all women 
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abstract) 
Robinson et al 
2002 UK, 
Prospective 
128 women with OAB with normal or 
equivocal urodynamics referred for 
ambulatory urodynamics. 
Clinician performing  urodynamics were 
blinded to BWT  
Measurement of  transvaginal 
BWT  
(Khullar’s technique) 
Ambulatory 
urodynamics- DO 
diagnosed if detrusor 
pressure rise was 
recorded in association 
with symptoms of 
urgency and/ or urge 
incontinence  
Khullar et al 1996 
UK, Prospective 
184 patients attending clinic for 
laboratory urodynamics  
DO=107 women Normal urodynamics 
but with a mean BWT >5mm who 
underwent ambulatory urodynamics=42 
BWT after emptying bladder 
post micturition residual was 
checked to ensure <50 mls. The 
measurements were made at 
maximum magnification in 3 
places: Perpendicular to the 
luminal surface at the thickest 
part of the trigone, dome and the 
anterior wall .Mean BWT = 
dome+ anterior wall+ trigone/3 
Videourodynamics per 
ICS standard BWT 
<3.5mm or with >5mm 
but no DO went onto 
have ambulatory 
urodynamics on a 
separate day  
Urodynamics  observer 
was blinded to BWT 
results 
Khullar et al 1994 
UK, Prospective 
45 women 
Detrusor instability =19  
SUI =20. 
Technique as described above. 
Operator performing BWT was 
blinded to urodynamic diagnosis 
Video urodynamics in 
supine position  
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Table 3: Characteristics of the included studies for the systematic review on BWT by transabdominal 
BWT/DWT  
 
 
Study, date, 
country, design 
Population Test Reference Standard 
Silva et al, 
2014,Brazil, 
Cohort study-
Prospective 
272 women with spinal 
cord injury 
BWT measured transabdominally 
midway between anterior wall of the 
bladder and the  lateral bladder wall 
Multichannel urodynamics along 
with urethral external sphincter 
myography  
Ozturk et al 
2011,Turkey, 
Case-control Study 
Conference 
abstract 
82 women: 
DO=39, SUI=43,  
Controls=31 
Transabdominal DWT at 200ml 
volume at three different places-
anterior wall, right and left lateral wall. 
Women were categorised into 
SUI and DO based on 
urodynamics 
Chung et al, 2010, 
Taiwan, 
Prospective Case 
control 
122 women-83 cases 
Normal  
urodynamics=28 
Increased bladder 
sensation=30 
 DO=30 
Normal controls=39 
Transabdominal DWT was measured at 
natural bladder filling and during 
catheter filling.  
88 Women underwent Video- 
urodynamics 
Kuo 2009,Taiwan 
Prospective Case 
control 
92 women OAB=81 
Controls=11 
Transvaginal detrusor 
wall thickness(DWT) 
scan on empty bladder 
and transabdominal 
DWT at bladder 
capacity 
Transvaginal DWT was measured at 
bladder neck, bladder base, anterior 
and posterior wall 
Trans-abdominal DWT was measured 
on the anterior wall at three sites 
All women underwent video-
urodynamics 
Blatt et al 2008, 
Australia, 
Prospective cohort 
180 patients including 
107 women.  
Normal  
urodynamics=69, 
BOO=39,  
Increased bladder 
sensation=38  
DO=34 
Mean BWT of two transabdominal 
BWT measurements on the anterior 
bladder wall, 1 cm apart in the midline 
at 200 ml bladder volume 
Video urodynamics as per the ICS 
standards 
Chan et 
al,2005,Australia, 
Prospective cohort 
study,(Conference 
abstract) 
86 women with OAB:  
Normal 
urodynamics=42,  
Sensory urgency=22 
DO=22 
Transabdominal BWT. Two 
measurements of anterior BWT (1 cm 
apart in midline at 200 mls filling and 
at capacity 
Urodynamics method  not 
specified 
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Table 4: Results of studies included in the systematic review of the accuracy of ultrasound 
measurement of BWT in diagnosing DO 
Study, date, 
country, 
design 
ROC/AUC Sensitivit
y 
Specific
ity 
Mean 
among 
those with 
DO(+/- 2SD 
or 95% 
confidence 
interval) 
Mean among those 
without DO(+/- 2SD 
or 95% confidence 
interval) 
Comments 
Otsuki et al, 
2014,Brazil, 
prospective 
case control 
study 
The ROC 
revealed an area 
under the curve 
of 0.962 (95% 
CI, 0.90–1.01) 
for BWT as a 
diagnostic 
marker.  
  6.2mm 4.5mm BWT and vesical pressure at 
involuntary detrusor 
contraction (𝑟 = 0.39, 𝑃 = 
0.017) were directly correlated 
Silva et al, 
2014,Brazil, 
AUC = 0.624, 95 
% CI (0.530, 
0.718), p = 0.011 
  4.2mm in 
neurogenic 
DO/DSD 
3.6 mm in  reduced 
bladder compliance 
 
Abou-
Gamrah et 
al,2014, 
Egypt 
AUC =0.905 90% 78 %    BWT cut-off  used=4.78 
 
Kuhn et al, 
2011,UK, 
Prospective 
Cohort study 
 
A single ROC 
curve was 
constructed for 
all the three 
conditions-SUI, 
DO and 
obstruction. AUC 
=0.87 (95% CI 
0.78–0.97; P < 
0.0001) for 
predicting 
different kinds of 
UI! 
90.6% 
(4.4 mm 
BWT 
cut-off) 
 
83.3%  
(5.6mm 
cut-off) 
96.6% 
(4.4 
mm 
BWT 
cut-off) 
 
87.5% 
(5.6mm 
cut-off) 
4.97±0.63
mm  
3.78 ±0 .39mm  
 
Outflow obstruction: 6.01± 
0.73mm ( P < 0.0001)  
 
Ozturk et al 
2011,Turkey 
  87.1%  
 
60.8%  
 
  At a cut off of 4.88mm  
PPV =53.9%  
NPV=90% 
Ibrahim 
et.al,2011.U
K, Egypt 
AUC =0.73.  70% 74% 7.79mm 6.60 mm BWT cut off of 4.48mm, PPV 
=73% and NPV = 71% for 
OAB 
Panayi. et 
al,2010,UK 
 
     BWT > 5mm in 65% of 
women with DO 
BWT > 5mm in 85% of 
women with OAB 
Chung et al, 
2010, 
     No difference of DWT in 
women with DO compared to 
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Taiwan 
 
 
OAB without DO or from the 
asymptomatic control group at 
a bladder volume of 250–
300ml. 
No difference in the DWT 
between natural filled and 
catheter filled bladders at 
250ml volume 
Serati. et al 
2010 
Italy,  
AUC for urgency 
incontinence=0.6
45, pure DO= 
0.702 and all DO 
(provoked as well 
as spontaneous 
DO) = 0.704. 
    Positive predictive 
value=100% for all DO at a 
cut-off of 6.5mm 
Kuo 
2009,Taiwan 
 
Natural filling: 
On ROC curves, 
transabdominal 
DWT cut off of 
0.75 mm at 
bladder 
capacity(AUC of 
0.776, standard 
error 0.068, 95% 
confidence 
interval 0.643, 
0.909) 
Catheter filling: 
The AUC was 
0.648, standard 
error of 0.078, 
95% confidence 
interval 0.495, 
0.802) 
73% 67%   No difference in transvaginal 
DWT at the bladder neck, 
anterior wall, posterior wall, 
and bladder base among 
women with DO, OAB 
without DO or normal 
controls. Transabdominal 
DWT was greater in DO 
group at maximum capacity.  
 
Lekskulchai 
et al 2008  
Australia 
 
AUC= 0.606 
(0.56-0.65) 
37% 79% DWT in 
DO=4.7+/-
1.9mm  
 
DWT in normal 
women=4.1 ± 
1.6mm 
(P<0.001) 
For 5 mm DWT cut-off 
Blatt et al 
2008, 
Australia, 
   1.9mm Normal 
urodynamics=2.0 
BOO=2.1, 
Increased bladder 
sensation =1.8 mm 
 
No  difference in the mean 
BWT between the groups  
(ANOVA p = 0.064) 
Minardi et al 
2007  
Italy 
 
    Urgency 
incontinenc
e= 
7.1 
+/1.6mm  
USI=4.1 +/-1.1mm  
Controls=3.9 +/-
1.9mm (P=0.019) 
 
Parsons et    4.862mm 4.085mm in OAB 
without DO 
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al,2005,UK Controls=3.92 
Chan et 
al,2005,Aust
ralia 
 
 
   1.7mm Normal 
urodynamics=1.7m
m, Sensory 
urgency=1.6 
No difference between BWT 
at 200 mls and at cystometric 
capacity. 
No difference between BWT 
in normal urodynamics vs 
BWT in DO and sensory 
urgency. Mean BWT in 
patients and DO = 1.7 mm, (p 
= 0.18). 
Yang et al 
2003  
Taiwan 
 
DO= Thickened 
bladder wall 
found in all 
LUTS except 
hypersensitive 
bladder-a 
nonspecific 
marker for 
several LUTS 
  5.5  
(5-6.6)mm  
 
USI= 
5.6-6.4 mm  
MUI= 
5-6.2mm  
 
 
Yang et al 
2002, 
Taiwan, 
Retrospectiv
e case 
control 
Mean BWT of 
Detrusor 
instability (DI)-,  
  5.8 ± 1.9 SUI-6.0 ± 2.4, 
Hypersensitive 
bladder=5.3 ± 1.9 
Controls= 4.9 ± 2.1 
Negative correlation between 
BWT at trigone and dome to 
that of resting bladder neck 
angle (P =0.006 and 0.019, 
respectively) 
Soligo et al, 
2002, 
Italy and UK 
   5mm with 
95% CI of 
4.6 and 5.3  
3.6mm CI of 3.4 
and 3.9 
PPV of BWT=83.3% NPV= 
83.2% 
Robinson et 
al 
2002 UK, 
Prospective 
 
 
  6.7 (95% 
CI 6-
7.4)mm 
Normal=5.1mm 
(95% CI 4.6-5.6)  
USI=4.8 mm (95% 
CI 4.4-5.3)  
MUI=5.8mm (95% 
CI 5.1–6.5) 
 
Khullar et al 
1996 UK 
For a BWT cut 
off of 5mm, 
Sensitivity= 84 
Specificity=89 
84 (75.8 
- 89.7)%  
 
89(78.8
- 
96.11)
% 
   
Khullar et al 
1994 UK 
Mean BWT    6.7 GSI =3.5  
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Chapter 3 
Accuracy of bladder wall thickness on transvaginal ultrasound in 
diagnosing Detrusor Overactivity: Materials and Methods 
Introduction 
From the systematic review in chapter 2 it was obvious that there was a lack of consensus on 
the standardisation of the technique, route of BWT, optimisation of cut off in diagnosing DO.  
A prospective, appropriately designed, adequately powered, multicentre diagnostic accuracy 
study was planned [Accuracy of bladder wall thickness ultrasound in the diagnosis of 
Detrusor Overactivity (BUS study)]. It was approved by Nottingham Research Ethics 
Committee (ethics no10/H0408/57) and funded by the National Institute of Health Research/ 
Health Technology Assessment Board. The study has been carried out in 22 centres in the 
UK. The units also represented the spectrum of patients, from a busy district general hospital 
to tertiary referral centres. Using recommended methods for diagnostic accuracy evaluation 
(Irwig et al. 2002), a prospective study protocol was developed with a classic test accuracy 
design and reported according to the STARD standards (Bossuyt, Reitsma, Bruns, Gatsonis, 
Glasziou, Irwig, Lijmer, Moher, Rennie, & de Vet 2003). Nottingham Research Ethics 
Committee and NHS trust research governance approval was obtained for 22 recruiting 
hospitals in the UK with the Birmingham Women’s Hospital and University of Birmingham 
acting as the study sponsors. Recruiting hospitals included both specialised tertiary referral 
centres and district general hospitals. Our study population was drawn from a large 
socioeconomically and ethnically diverse group of women. The study was monitored by an 
independent data monitoring committee.  
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3.1 Study design 
The study evaluated the accuracy of bladder wall thickness ultrasound (BWT) in making a 
diagnosis of DO using laboratory multichannel urodynamics as the reference standard. For 
the index test, BWT was measured on transvaginal ultrasound scans, which is a continuous 
variable reported in millimetres.  
3.2 Eligibility 
Inclusion criteria 
• Frequency of 9 or more voids in 24 hours on at least 1 out of the 3 days on bladder 
diary  
• Mild – severe urgency on at least one occasion in 3 day bladder diary 
• Post void residual (PVR) volume <100 mls on screening 
• Written informed consent  
• If patient has had previous stress urinary incontinence (SUI) surgery &/or Botox, it 
was >6 months ago 
Exclusion criteria 
• Pregnancy and up to 6 weeks postpartum. 
• Symptoms of SUI or stress predominant mixed incontinence 
• Evidence of cystitis (dipstick positive for leucocytes/nitrites) 
• Voiding difficulties (PVR >100 ml)   
• Prolapse > grade II (any compartment) 
• Urodynamics assessment in the past 6 months  
• Use of antimuscarinics for more than 6 months continuously 
• Current use of anti-muscarinics (e.g. Tolterodine, solifenacin and oxybutynin) 
57 
 
• If the woman is taking anti-muscarinics for <6 months at the point of consent, she will 
be eligible if the medication is ceased immediately and there is a delay of at least 2 
weeks until the index and reference tests are carried out 
3.3 Sample size 
A minimum target sample size of 600 women was pre-specified in order to obtain estimates 
of sensitivities and specificities with 95% confidence intervals of width 10% or less 
anticipating sensitivity and specificity values between 70% and 95%. The computation was 
based on a prevalence of 50% for DO (Hashim & Abrams 2006), providing 300 women each 
for the estimate of sensitivity and specificity.  
3.4 Recruitment of participants and consent 
The potential participants referred with frequency and urgency to the urogynaecology, 
urology or urodynamics clinics were identified and study information leaflets were sent along 
with their appointment letters. Study information leaflets were also given to women who 
presented primarily with prolapse (grade 2 or less) but had coexisting urinary frequency and 
urgency symptoms.  
 
Patients who fulfilled the entry criteria were approached and consent was sought from the 
willing in a two stage process. The study information leaflets along with a sample consent 
form and bladder diaries were posted to all prospective participants with their clinic invitation 
letter. Research nurses and principal investigators in the recruiting hospitals were trained to 
consent participants by reinforcing the information provided and answering any questions 
that the women may have had. Women were provided enough time for consideration and 
opportunity to ask questions and then approached for consent and study recruitment. 
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Wherever necessary, appropriate interpreters were used to aid discussion relating to study 
participation.  
 
All of the recruiting nurses and the doctors were trained regarding the introduction of 
information about the study and instruction on their roles from the local coordinating 
clinicians and the by the Clinical Research Fellow. Team meetings were organised and 
newsletters periodically sent to reinforce the study recruitment and procedures from the Study 
Office. A screening log was maintained for the women screened including those who agreed 
to participate and also those who declined participation.  
 
Recruitment was organised and supported by a dedicated team under the supervision of 
clinical principal investigator (PI). Documentation was provided by the BUS Study Office 
and the clinical research fellow supported clinics in some centres local to Birmingham. The 
Clinical Research Fellow (SR), liaised with the local PI at each centre, provided ultrasound 
scan (USS) training, recruited patients at the main centre, dealt with any problems with 
recruitment and conducted quality assurance of the scans. 
3.5 Setting of tests 
Urodynamics was carried out by health care professionals (doctors or nurses) who were 
already carrying out the procedure in routine clinical practice. For BWT scanning, hands on 
training was delivered on site for each of the recruiting sites for the clinicians (doctors or 
sonographers) and two scan training workshops were carried out at the Birmingham 
Women’s Hospital. 
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At centres, where the BWT scan was done in the radiology department, the urodynamics was 
carried out blinded to the ultrasound result, within 4 weeks of the BWT scan. If this 4 week 
cut-off period was breached, there was a further 4 week window in which the second test data 
was collected, but classed as a protocol violation. Both the urodynamics and BWT were 
performed by independent observers blinded to each other. 
3.6 The index test: Bladder ultrasound 
BWT was measured with the transvaginal ultrasound probe in the sagittal plane, introduced 
1cm beyond the vaginal introitus in the midline. The participants were advised to pass urine 
and the PVR urine was measured using the technique described by Haylen (Haylen 2007). 
The BWT was measured at a PVR volume of less than 30ml as the thickness was found to be 
fairly constant when measured in the range of bladder volumes of 0-50ml (Khullar, Salvatore, 
Cardozo, Bourne, Abbott, & Kelleher 1994). If the bladder had >30 mls PVR, participant was 
asked to double void and the PVR was measured again. If the PVR was </=100mls then the 
patient was included in the study. 
 
The thickness of all the three layers of the bladder wall- serosa, the detrusor muscle and the 
urothelium was measured on transvaginal ultrasound and a mean BWT calculated. The sites 
of BWT measurement on the anterior wall, trigone and dome was chosen based on the 
previous evidence (Khullar, 1994) (Robinson, 2002) .The average BWT calculated from three 
site measurement of anterior wall, dome and trigone might be a better representative of  BWT 
better than by measuring dome thickness alone. The technique and settings for BWT has been 
described in chapter 1 pages 27 and 28. Figure 7 depicts the measurement of a thickened bladder 
wall. 
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Figure 7: Thickened bladder wall as seen on transvaginal scan 
 
The margins of the bladder wall were found to be more clearly visualised by the transvaginal 
route, as the more distant the probe was from the visualised structure, the higher the 
attenuation of ultrasound waves resulting in poor-quality images. The interobserver 
variability in BWT measurement was found to the lowest in transvaginal scan compared to 
transabdominal and transperineal scanning(Panayi, 2010). Hence we have chosen 
transvaginal route in measuring BWT. For the standard operating procedure followed  
for BWT, please see Appendix 6 a. 
3.7 The Reference Standard-Urodynamics 
Urodynamics is considered ‘gold standard’ for investigation of LUTS and has been 
universally adapted (Abrams 2006). Urodynamics is believed to provide an explanation to the 
pathology behind LUTS by reproduction of patients symptoms(Abrams et al. 2009). The test 
is accompanied by imaging during video urodynamics.  
Urodynamics are performed in three stages (Abrams 2006): 
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1. Uroflowmetry 
2. Filling cystomtery 
3. Voiding cystometry 
Uroflowmetry is a noninvasive study of assess voiding pattern of the bladder. Uroflowmetry 
is carried out by asking the patient with a reasonably full bladder to void in a flowmeter in 
privacy. Uroflowmetry is used to diagnose bladder outflow obstruction and also as a measure 
of voiding function (Abrams 2006). 
 
Cystometry is an interactive test of the storage (filling cystometry) and the voiding function 
(voiding flowmetry) of the bladder. The filling phase is recorded on cystometrogram as 
variations in detrusor pressure with incremental filling. Detrusor pressure is calculated by the 
subtraction of abdominal pressure from the vesical pressure. The rate of filling the bladder 
should be based on patient’s symptoms. Bladder sensation, bladder pain, detrusor activity, 
compliance of the bladder wall and cystometric capacity may be studied during filling 
cystometry (Abrams 2006;Abrams, Artibani, Cardozo, Dmochowski, van, & Sand 2009).  
 
The coordination between detrusor activity and urethral function may be studied during 
voiding cystometry. Detrusor underactivity, detrusor sphincter dyssynergia and dysfunctional 
voiding may be diagnosed during this phase of urodynamics (Abrams 2006). Provocation 
tests like coughing and running taps are carried out to detect provoked DO (Abrams 
2006).For the standard operating procedure followed for urodynamics, please see  
Appendix 6 b. 
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Laboratory urodynamics is chosen as the reference standard as it is the most common 
urodynamic procedure used in investigating LUTS around the world. Laboratory 
urodynamics has been criticized to be not a very physiological test due to the short duration 
involved, retrograde filling using a urethral catheter and the rapid filling of the bladder which 
might be much faster than the physiological rate of urine production.  
 
Ambulatory urodynamics may be a used when patients with troublesome urinary 
incontinence have normal urodynamics (Swithinbank et al. 1999). During ambulatory 
urodynamics, bladder is allowed to fill naturally, bladder pressure is measured by a micro-
transducer and the patient is allowed to move around mimicking a physiologic state. 
Ambulatory urodynamics may have a higher pickup rate of DO and have shown better 
correlation to clinical symptoms (Radley et al. 2001). However, in studies of healthy 
asymptomatic volunteers, 16% on laboratory urodynamics and 48% of women on ambulatory 
urodynamics were diagnosed to have DO indicating a high false positive rate (Heslington and 
Hilton 1996). Moreover, the technique of ambulatory urodynamics is more time consuming, 
has not been standardised and not universally available. In the present study, ambulatory 
urodynamics was offered to women with OAB symptoms if they had normal urodynamics 
but only at the Birmingham Women’s Hospital.  
3.71 Urodynamics in Overactive bladder (OAB) 
Detrusor Overactivity (DO) is defined as the urodynamic observation of involuntary detrusor 
contractions during the filling phase of cystometry which may be spontaneous or provoked 
(Abrams 2003). DO was observed in 44% of OAB dry and 58% of OAB wet patients in a 
study by Hashim and Abrams (Hashim & Abrams 2006). DO may be classified into 
idiopathic (absence of a defined cause) and neurogenic DO (presence of a neurological 
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condition). Also, DO may be phasic where the individual experiences urgency but may or 
may not have incontinence and terminal DO where there seems to be a single involuntary 
uninhibited contraction emptying the bladder (Abrams 2003). Bladder compliance is a 
mathematical calculation obtained by dividing the change in bladder volume (DV) by the 
detrusor pressure change (D Pdet) during that change in bladder volume (DV/DP det). It 
gives an indication on the elasticity of the bladder wall. 
 
Presence of artefacts may mislead and interfere with the diagnosis. Abdominal pressure 
artefacts appear when patients strain during voiding or with rectal peristalsis, making it 
difficult to see whether detrusor activity was present (Hogan et al. 2012) Evidence on the 
reproducibility of urodynamic findings is conflicting (Homma et al. 2000). 
3.8 Statistical methodology for diagnostic accuracy of BWT 
A statistical analysis plan with proposed methods to analyse study data on the accuracy of 
BWT in the diagnosis of DO was drawn a priori. 
3.81Primary analysis 
3.811Diagnostic accuracy of BWT scan  
Calculations of test accuracy-sensitivity, specificity, predictive values and likelihood 
ratios(Altman, 1994 112 /id) (Altman, 1994 111 /id) (Altman, 1994 113 /id) using a BWT of 
5mm as a cut-off (>=5mm indicating presence of DO, <5mm indicating absence of DO) were 
planned. Using binomial exact methods, 95% CIs will be calculated for all estimates (Clopper 
C, 1934) . The cut off of 5mm mean BWT in diagnosing DO was based on previous evidence 
from a systematic review on the diagnostic accuracy of BWT (Latthe, 2010).  
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3.82 Secondary analysis 
Likelihood ratios for BWT will be calculated (along with 95% CI) for the three BWT cut-
offs: <3mm / >=3mm to <5mm / >=5mm. A ROC curve (Altman, 1994 ) will be constructed 
(plot of sensitivity versus 1-specificity) (e.g. every 0.25mm) between the highest and lowest 
measurements obtained for exploration of an ‘optimum’ cut-off of BWT. Accuracy estimates 
will be reported along with estimates at the Q* threshold (point where sensitivity and 
specificity are maximised). The area under the ROC curve (probability that a random person 
with DO has a higher measurement of BWT than a random person without DO, with 0.5 the 
lowest possible value and 1.0 the highest) will also be calculated, along with a 95% CI, as an 
overall estimate of BWT accuracy. Statistical significance will be tested by comparing 
against the uninformative model (i.e. where AUC=0.5) using a non-parametric 
approach(Xiao-Hua Zhou NAO and Donna K.McClish 2011). A t-test on BWT comparing 
those with a positive and negative diagnosis of DO will be performed and box-and-whisker 
plots generated. 
3.83 Subgroup and other analysis 
Estimates of accuracy (as per the primary and secondary outcomes) within subgroups will be 
calculated for the following variables: 
previous treatment with antimuscarinics 
clinical history suggesting mixed incontinence 
presence of urinary tract infections in previous 12 months 
patients with voiding difficulties 
patients who also have ambulatory urodynamics for DO verification 
past history of incontinence surgery  
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The importance of these subgroups will be explored using a logistic regression model with 
sensitivity or specificity as the outcome variable and a variable representing the subgroup as 
the explanatory variable. Odds ratio, 95% CI and related p-values will be calculated for these 
analyses. 
 
Other exploratory analysis will include a multivariable logistic regression analysis to explore 
possible predictors of DO. Combinations of history (which includes the subgroup variables 
listed above along with, but not limited to: age, menopausal status, parity, body mass index) 
and BWT will be used as the explanatory variables with the urodynamic diagnoses (DO: 
yes/no) as the dependent variable.  
3.84 Sensitivity analysis 
Sensitivity analysis including missing explanatory variable data inputted though multiple 
imputation techniques will be performed. Where urodynamics were performed without 
blinding to the results of the ultrasound, exploratory sensitivity analysis will be performed 
without these tests to see how this affects the primary and secondary outcomes. Sensitivity 
analysis will also be completed for those patients with more than four week interval between 
the ultrasound and urodynamics. 
3.85 Missing outcome data 
The study will carry on recruiting until we have reached at least 600 patients who have been 
through the ultrasound and urodynamics. Missing data items will be flagged to the data 
manager through the data entry system at the entry stage.  
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If all three(dome, trigone and anterior wall) of the ultrasound measurements used to calculate 
mean BWT are unavailable (following a review by the data manager and statistician) then 
these results will not count towards the final recruitment total. If one or two of the three 
measurements are unavailable then the average BWT will be calculated from the remaining 
data. A sensitivity analysis will be performed without these particular results to see how this 
affects the primary and secondary analysis. The flow chart of patient pathway including the 
statistical methods is depicted in figure 8 below. 
Figure 8: Study flow chart 
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Chapter 4: Accuracy of transvaginal bladder wall thickness in diagnosing 
detrusor overactivity: Results 
Introduction 
A diagnostic test is used to predict the post-test probability of a disease, i. e, discriminate a 
person with the disease from a person without the disease. The threshold at which a test result 
is significant needs to be determined if the result is reported in continuous variables. 
Accuracy of the test in discriminating disease positive and disease negative states at that 
threshold needs to be ascertained to interpret the test result (Mallett et al. 2012).With a new 
diagnostic test is considered, rigorous evaluation of its accuracy is necessary to prevent or 
minimise its inappropriate use and interpretation, thus minimising any harmful or unwanted 
clinical consequences . 
 
This chapter describes a prospective test accuracy study to determine the accuracy of bladder 
wall thickness (BWT) in diagnosing detrusor overactivity (DO) in women with overactive 
bladder (OAB) symptoms.  
Population: Women with OAB or urgency predominant mixed incontinence 
Index test: BWT on transvaginal ultrasound scan 
Reference standard: Multichannel urodynamics  
Outcome: Diagnosis of DO. 
4.1 Index test - bladder wall thickness via ultrasound 
For the technique of bladder wall thickness, please see chapter 3 and appendix 6a for the 
standard operating procedure (SOP). 
68 
 
4.2 Reference standard – Urodynamics 
Please refer to appendix 6b for the SOP for urodynamics. The aim of urodynamics was to 
reproduce patient’s symptoms and correlate them with the changes in detrusor pressure. The 
effect of bladder filling on the patient’s perception of symptoms was assessed. Table 8 
depicts the various urodynamic parameters in the study population. 
4.3 Data analysis  
The detailed statistical methods for primary and secondary analyses have been elaborated in 
chapter 3 under the sections 3.81 and 3.82 in pages 64 and 65. The sensitivity analyses were 
performed as previously planned and documented in the appendix section.  
4.4 Results 
4.41 Recruitment of participants in the BUS study 
Recruitment of participants started in January 2011 and closed in March 2013. A total of 
1310 women were approached and the course of recruitment from March 2011 to march 2013 
is depicted in figure 9. Our study recruitment was faster than the projected course as seen in 
figure 9. Six hundred and eighty seven women, consenting to participate were recruited into 
the study from 22 centres. Details of recruitment of study participants from each centre is 
given in table 5. The study over-recruited to compensate for withdrawals and also to 
accommodate the participants who did not undergo either the index or the reference standard 
tests.  
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Figure 9: Progress of recruitment of patients in the BUS study 
 
Majority of the patients were recruited from Birmingham Women’s Hospital (n=254) followed by 
Medway Maritime Hospital (n=109) (Table 5). 
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Table 5: Recruitment by centre 
Recruiting Centre Number  
Birmingham Women’s Hospital 254 
Medway Maritime Hospital, Kent 109 
Mayday University Hospital, Croydon 92 
Basingstoke and North Hampshire Hospital 30 
St Mary’s Hospital, Manchester 26 
Staffordshire General Hospital 26 
Stepping Hill Hospital 25 
Ormskirk & District General Hospital 19 
New Cross Hospital, Wolverhampton 16 
Royal Bournemouth General Hospital 16 
The Alexandra Hospital, Redditch 14 
City General Hospital (University Hospital of North 
Staffordshire) 
10 
Crosshouse Hospital, Ayrshire 9 
Manor Hospital, Walsall 8 
Northampton General Hospital 6 
Royal Hallamshire Hospital, Sheffield 6 
Derriford Hospital, Plymouth 5 
Pinderfields General Hospital 4 
St Mary’s Hospital, Paddington 4 
Southern General Hospital, Glasgow 3 
The Royal London Hospital 3 
Sandwell General Hospital, Birmingham 2 
Total 687 
 
4.42 Demographics of study population: 
The study population represented the typical OAB spectrum of patients. The mean age of 
women was 52.7 years (SD 13.9) with an average BMI was 30.6 (SD 12.2). Fifty five percent 
(387/687) of the women were postmenopausal. According to the clinical history 61% 
(419/687) of the women had urgency predominant mixed incontinence and 33% (226/687) 
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reported only urinary urgency along with increased frequency. The median duration of 
symptoms was 3.0 years (IQR: 1.6, 7.0) (Table 6). 
Table 6: Characteristics of patients in the BUS study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age (years) Mean (SD) 52.7 (13.9) 
Missing 0 (-) 
Ethnicity 
White British/Irish/Other  538 (78%) 
Asian Pak/Ind/Bang/other 72 (10%) 
Black Carrib/African/other 49 (7%) 
Mixed/other 18 (3%) 
Not given/missing 10 (1%) 
Parity  
0 69 (10%) 
1 90 (13%) 
2 241 (35%) 
3 152 (22%) 
4 56 (8%) 
>4 63 (9%) 
Missing 16 (2%)   
Post-menopausal (lmp>1 year) 
Yes 378 (55%) 
No 293 (43%) 
Missing 16 (2%) 
BMI (kg/m2) 
Mean (SD) 
Missing 
 
30.6 (12.2) 
28 
Incontinence type 
Mixed urinary incontinence 419 (61%) 
Urgency  incontinence alone 226 (33%) 
Stress  incontinence alone 4 (1%) 
Neither 19 (3%) 
Missing 19 (3%) 
  
If mixed, what started first (n=419)? 
Urgency 226 (54%) 
Stress 107 (26%) 
Unsure 54 (13%) 
Missing 32 (8%) 
Current or previous treatment with anti-
muscarinics 
Yes 226 (33%) 
No 444 (65%) 
Missing 17 (2%) 
Recurrent cystitis (3 or more in last 12 
months) 
Yes 50 (7%) 
No 606 (88%) 
Missing 31 (5%) 
Voiding difficulties 
Yes 286 (42%) 
No 374 (54%) 
Missing 27 (4%) 
Vaginal birth 
Yes 561 (82%) 
No 95 (14%) 
Missing 31 (5%) 
Previous incontinence surgery 
Yes 36 (5%) 
No 623 (91%) 
Missing 28 (4%) 
Previous POP/UI surgery 
Yes 56 (8%) 
No 603 (88%) 
Missing 28 (4%) 
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Following consent, the flow of patients through the diagnostic pathway (index test and reference 
standard is shown in figure 10. 
Figure 10: Participant flow diagram 
 
 
 
 
 
 
 
 
 
The number of participants with a complete reference standard diagnosis was 644/687 (97%). 
The other 21 (3%) decided to withdraw from the study before any testing could take place 
(Figure 10).  
4.43 Index Test and the Reference Standard 
The majority of the participants 68% (446/660) had both BWT scan and urodynamics 
performed on the same day. Only a small proportion (26/660, 4%) were performed more than 
four weeks apart. No serious adverse events were reported following either test, although 
49/479 (10%) of the respondents reported having a UTI within two weeks of testing at six 
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73 
 
month follow-up; 36/48 (75%, ) of these were diagnosed by a General Practitioner or in a 
hospital and resulted in antibiotic use in the 83% of cases (39/47 83%). 
4.431 Bladder wall thickness  
The number of participants with all three BWT measurements (trigone, dome midline, 
anterior wall midline) available was 645 (94%). Of the remainder, 32 (5%) withdrew from 
the study or were lost to follow-up and did not have any recorded measurements and 10 (1%) 
had partial measurements recorded (9 with 2/3 of the measurements and 1 with 1/3 of the 
measurements). Summary statistics and distribution of BWT are provided in Figure 11. 
Figure 11: Histogram of average bladder wall thickness measurements  
 
4.432 Urodynamic findings 
The number of participants with a complete reference standard diagnosis was 666 (97%), the 
other 21 (3%) were withdrawn from study or lost to follow-up. Of these, 399 (60%) were 
diagnosed with DO (95%CI: 56% to 64%) (Table 7). Of the 399, two hundred and forty-five 
were given further sub-diagnosis of ‘wet’ DO (DO with urinary incontinence) (61%) and 154 
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contraction occurred during or after provocation tests like cough, star jumps, running water or 
immersion of hands in cold water: 56/369). Details of the measurements made in this testing 
are given in Table 8. Of these, 399 (60%) were diagnosed with DO (95%CI: 56% to 64%). Of 
the 399, two hundred and forty-five were given a further sub-diagnosis of ‘wet’ DO (61%) 
and 154 as ‘dry’ DO (39%). The participants also had their DO diagnosis sub-categorised as 
systolic or ‘spontaneous’ DO (detrusor contraction during the filling phase: 182/369, 49%, 30 
observations missing), provoked DO (if the detrusor contraction occurred during or after 
provocative measures like cough, running water or immersion of hands in cold water: 56/369, 
15%), or both (131/369, 36%)(Table 8).  
Table 7: Summary of all urodynamic diagnosis in the cohort of women recruited in this study 
(n=666) 
Including DO (n=399) Numbers (%) 
DO only 258 (39) 
DO+USI 97 (15) 
DO+ voiding dysfunction (VD) 18 (3) 
DO+USI+VD 12 (2) 
DO+ Low compliance (LC)  8 (1) 
DO+USI+LC 5 (1) 
DO+USI+LC+VD 1 (<1) 
Not including DO (n=267)  
Normal 124 (19) 
USI only 78 (12) 
LC only 36 (5) 
VD  only 14 (2) 
USI+VD 8 (1) 
USI+LC 6 (1) 
LC+VD 1 (<1) 
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Table 8: Urodynamic parameters in the BUS study (n=666)  
Uroflowmetry  
 Frequency (%) for binary data, median [IQR] for 
continuous data, n=number of values recorded 
Patient had comfortably full bladder=yes 502/655 (77%) 
Volume voided, ml 129 [58, 245], n=627 
Post void residual volume, ml 10 [2, 40], n=619 
Maximum flow rate, ml/sec 16 [9, 25], n=596 
Filling cystometry  
Patient in recommended sitting position for test=yes 457/664 (69%) 
Fill rate, ml/min 100 [70, 100], n=660 
First desire, ml 135 [84, 197], n=644 
Normal desire, ml 200 [140, 268], n=587 
Strong desire, ml 272 [199, 357], n=562 
Pain (if reported), ml 300 [203, 395], n=154 
Leakage (if applicable), ml 10 [0, 100], n=229 
Total volume in bladder at the end of filling, ml 421 [314, 498], n=639 
Rise in detrusor pressure upon filling=yes 350/598 (59%) 
Detrusor pressure at start, cm/H2O 0 [-1, 1], n=638 
Detrusor pressure rise on filling to 500 ml, cm/H2O 12 [6, 21], n=576 
Detrusor pressure rise when complaint of urgency, 
cm/H2O 
12 [5, 21], n=557 
Provocation test (where performed)  
Detrusor pressure rise with cough=yes 101/517 (20%) 
Detrusor pressure rise with running tap=yes 119/367 (32%) 
Detrusor pressure rise with exercise 39/124 (31%) 
Flow cystometry  
Peak flow rate, ml/sec 20 [15, 28], n=624 
Maximum voiding pressure, cm/H2O 41 [29, 60], n=577 
Residual volume, ml 0 [0, 20], n=540 
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4.7 Estimates of test accuracy 
Six hundred and forty four participants had both complete index and reference standard 
results. Estimation of the accuracy of BWT showed poor sensitivity, specificity and 
likelihood ratios at the pre-specified cut-offs of 5mm (Tables 9 and 10), <3/3-5/>=5mm 
(Table 11) and overall (Figure 12). The AUC was 0.53, 95%CI: (0.48, 0.57) indicating that 
there was no evidence that BWT had any ability to discriminate between those with and 
without DO (p=0.25) (Figure: 12). Furthermore, there was no evidence that the mean BWT 
measurements were any higher in the DO positive group compared to the DO negative group: 
4.85mm (SD: 1.36) versus 4.70mm (SD: 1.29); p=0.19 (Figure 13) or that it had any 
relationship with ICIQ-OAB symptoms score when measured at presentation (r=-0.01; 
p=0.88) (Appendix: 5.3). 
Table 9: Comparison of index and reference standard results – dichotomised at 5mm 
  Reference standard (Urodynamics) 
  DO No DO Total 
Index test: 
BWT by 
ultrasound 
Positive Result (>=5 mm) 165 98 263 (41%) 
Negative Result (<5 mm) 223 158 381 (59%) 
Total 
388 (60%) 256 (40%) 644 
 
Table 10: Estimates of BWT test accuracy – dichotomised at 5mm  
 
Value 95% CI 
Sensitivity 43% 38 to 48% 
Specificity 62% 55 to 68% 
PPV 63% 57 to 69% 
NPV 41% 36 to 47% 
LR+ 1.11 0.92 to 1.35 
LR- 0.93 0.82 to 1.06 
77 
 
Table 11: Estimates of BWT test accuracy – trichotomised at 3, 3-5, >=5mm 
  Reference standard 
(Urodynamics) 
LR+ LR- 95% CI 
  DO No DO Total    
Index test: 
BWT by 
ultrasound  
++Result (>=5 
mm) 165 98 263 
1.11 0.93 0.92 to 1.35 
+ Results (3-5 
mm) 193 132 325 
0.96 1.04 0.83 to 1.13 
Result (<3 mm) 30 26 56 0.76 1.03 0.46 to 1.26 
Total 
388 (60%) 256 (40%) 644 
   
 
 
 
Figure 12: ROC curve analysis for BWT in the study population 
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Figure 13: Box and whisker plot comparing BWT with DO diagnosis  
Sensitivity analyses included construction of ROC curves and calculation of AUC and were 
limited to excluding those patients where it was revealed that the urodynamics test result was 
not blinded to the results of the ultrasound(Appendix:3 Figure 3.1); excluding those patients 
where there was more than four weeks between index and reference standard 
tests(Appendix:3 Figure:3.2); including results of incomplete ultrasound measurements, i.e. 
where not all three components of BWT were recorded (in these cases if one or two 
measurements were missing the average of the remaining values was taken to be 
BWT)(Appendix:3 Figure 3.3); replacing the original urodynamics diagnosis with that from 
the additional ambulatory urodynamics test where available (this only happened in fourteen 
instances all from one centre) (Appendix:3 Figure 3.4); using the trigone measurement alone 
as BWT(Appendix:4 Figure:4.5 ); excluding those who had ‘provoked DO’ (detrusor 
pressure rise upon provocation testing – 187 cases)(Appendix:4 Figure:4.6 ) & excluding 
those who had post void residual>30ml upon BWT testing (Appendix:4 Figure 4.7);. 
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The populations looked at in the exploratory analyses were: a) Women with urgency alone on 
clinical history (i.e. excluding those with mixed stress/urge incontinence) (Appendix: 4 
Figure 4.1); b) Women with ‘pure’ DO only (i.e. not alongside another diagnosis from 
urodynamics) (Appendix: 4 Figure: 4.2); and c) Women with ‘wet’ DO only (i.e. not 
including those with ‘dry’ DO) (Appendix: 4 Figure: 4.3). 
 
Subgroup analyses were performed by the generation of ROC curves for each 
subgroup.(Appendix 5,Table:5.1) The AUC for each subgroup was compared using a large 
sample chi-squared test for independent curves(Pepe 2004). The subgroups used here to 
dichotomise patient groups were: previous treatment with antimuscarinics, a clinical history 
suggesting mixed incontinence; presence of a urinary tract infection in the previous twelve 
months; voiding difficulties; previous incontinence surgery and the BMI (<25, >=25). 
 
An exploratory logistic regression analysis was undertaken to assess which variables may be 
associated with a diagnosis of DO. They included pre-test ICIQ score, BWT, age, duration of 
symptoms, ethnicity, vaginal birth, menopausal status, parity and previous POP surgery   
Covariates were considered individually and then in a multivariable analysis (Appendix: 5 
Table: 5.3). Three multivariable models were constructed: one using all possible explanatory 
variables; another using all possible explanatory variables but using a multiple imputation 
approach to generate missing responses (Schafer JL 1997) and another using a backward-step 
process to eliminate unimportant variables (a level of p=0.1 was used here as criteria for 
staying in the model). Whether BWT had any relationship with baseline ICIQ-OAB score 
using a simple linear regression model was also examined. 
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Sensitivity analysis or the unplanned exploratory analysis as described above did not change 
the interpretation of these findings. There was some evidence that those diagnosed with ‘wet’ 
DO had higher BWT than those with ‘dry’ DO (4.94mm vs. dry 4.69mm; p=0.08) (Appendix 
4.4). However, when the BWT for the wet DO group was analysed alone, the AUC was only 
0.55, 95%CI: 0.50, 0.59) (Appendix: 4 Figure: 4.3). There was no evidence that BWT 
performed any differently in any of the pre-specified subgroups (Appendix 5.1). 
 
In the multivariable exploration of factors possibly associated with DO diagnosis, only higher 
pre-test ICIQ score (i.e. worse symptoms) was associated with DO (OR: 1.21, 95%CI: 1.13, 
1.29; p<0.0001 from the model including all possible variables), i.e. the odds of DO 
diagnosis were increased by 21% for every point increase in ICIQ score (Appendix 5 Table: 
5.3). Previous treatment with antimuscarinics and previous urine infection in the last twelve 
months also showed some relationship but these were of borderline statistical significance. 
4.8 Discussion 
4.81 Summary of main findings 
To date, BUS is the largest diagnostic accuracy study to estimate the test accuracy of BWT in 
diagnosing DO. We could not find any evidence that BWT had any relationship with DO. It 
appeared to be no more accurate than chance at diagnosing DO with an AUC of 0.53(95%CI: 
0.48, 0.57) (Figure: 12). Extensive sensitivity analyses and subgroup analysis did not alter the 
interpretation of these findings. Based on this evidence, we conclude that BWT is not a useful 
test in diagnosing DO and should not be used clinical practice. 
4.82 Strengths and limitations  
The main strength of this study is its methodology. The protocol was drawn up ‘a priori’, peer 
reviewed and given robust oversight with six monthly meetings of independent Data 
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Monitoring and Study Steering Committees. Blinding of operators performing BWT scan and 
urodynamics was ensured for 610/629 (97%) women recruited into the study. Verification 
bias was minimised by incorporating a complete verification design. Disease progression bias 
was minimised by conducting BWT and urodynamics within a short time span of each other, 
often within the same day.  
 
A sample size calculation was performed to ensure that the study is powered to estimate 
diagnostic accuracy of BWT, and the study recruited beyond the target. A number of 
sensitivity analyses were performed on the primary population to test the robustness of the 
results to protocol deviations and missing data. Participants in the study were recruited from 
several centres (tertiary referral centres and district general hospitals) (Table 5).Women were 
of different ages, ethnicities and social background, recruited from various parts of UK, 
providing high level of generalisability across the NHS (Table 6). The spectrum variation 
(recruiting women from various ethnicities, varying degree of severity of OAB or urgency 
predominant mixed incontinence) in the study was a strength of the design, improving the 
generalizability of the findings. Exploratory analyses were performed to gauge the effect of 
changing the population of interest and also to see which parameters were associated with 
DO diagnosis and there was only some relation between ICIQ scores and DO. Furthermore, 
BWT had no relationship to ICIQ score upon presentation, indicating that it has no 
relationship with symptom severity. ICIQ score. 
 
It is believed that spontaneous DO is secondary to pathology in detrusor muscle whereas 
provoked DO is due to pathology in bladder neck. Provoked DO which was previously called 
urethral instability could be due to primary urethral aetiology (Ulmsten 1997;Ulmsten and 
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Falconer 1999). Based on the theory that bladder wall thickens with frequent detrusor 
contractions against a closed sphincter, a sensitivity analyses to evaluate diagnostic accuracy 
of BWT excluding those with provoked DO was carried out. However, the ROC for women 
with only spontaneous DO has shown an AUC of 0.54.indicating absence of any significance 
(Appendix: 4.6). 
 
The technique of transvaginal BWT measurement is easy to perform, with the urinary bladder 
being an anterior and relatively superficial midline structure. To standardize the performance 
of BWT scan, a standard operating procedure (SOP) for carrying out the ultrasound was 
developed (Appendix 6a). Hands on training at individual recruitment sites to the 
investigators was provided and two workshops were organised on BWT measurements. 
Quality assurance tests on both urodynamics and BWT were carried out. For the study 
findings to be reliable, uniformity in the conduct of recruitment/diagnostic testing is essential 
for multicenter clinical trials using urodynamics. With the use of regular training updates on 
standardized urodynamic testing procedures, interpretation guidelines and the quality 
assurance audits, the technical quality of urodynamics was improved. To improve reliability 
in the way BWT and urodynamics were carried out, several proactive measures were 
undertaken eg. standard urodynamic test protocol, guidelines for interpretation, audits of the 
traces centrally every six months, training and assessing competence in measurements of 
BWT, checking reproducibility of scans, independent data monitoring committee etc. 
 
In an update of the systematic review on the diagnostic accuracy of BWT in diagnosing DO 
(Chapter: 2); ten of the twenty one studies were of case-control design (Tables: 2 and 3). 
Seven of the ten case-control studies have shown a significantly increased BWT in DO 
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compared with patients without DO (Abou-Gamrah, Fawzy, Sammour, & Tadros 
2014;Ibrahim S & Najdy M 2011;Minardi, Piloni, Amadi, El, Milanese, & Muzzonigro 
2007;Otsuki E N, Júnior E A, Oliveira E, Castelo Girão M J B, & Jármy-Di Bella Z I K 
2014;Ozturk H, Aydur E, Irkilata H, Seckin B, & Dayanc M 2011;Parsons, Amundsen, 
Cardozo, Vella, Webster, & Coats 2007;Soligo M, Salvatore, Luppino G., Arcari V, Milani, 
& Khullar 2002) The results from these studies need to be interpreted with caution as the 
comparison with the ‘non disease controls’ in ten studies might have introduced significant 
bias by over-estimating the diagnostic accuracy of the test (Lijmer, Mol, Heisterkamp, 
Bonsel, Prins, van der Meulen, & Bossuyt 1999). All of the prospective and retrospective 
cohort studies on diagnostic accuracy of BWT also suffered from multiple weaknesses like 
absence of power calculation, being single centre (mostly tertiary) studies with limited 
generalizability, use of different routes of ultrasound like the transabdominal, translabial with 
varying bladder volumes during measurement and using additional reference standards like 
ambulatory urodynamics (Khullar, Cardozo, Salvatore, & Hill 1996;Robinson, Anders, 
Cardozo, Bidmead, Toozs-Hobson, & Khullar 2002). The methodology of these studies was 
not robust to draw meaningful comparisons with our study (Figures 3 and 4).   
 
Of the remaining 11 prospective and retrospective cohort studies, only five report test 
accuracy data (sensitivity and specificity). Except one study (Yang & Huang 2002) all others 
report significant differences in mean BWT between groups, but the difference was not 
significant enough to be used as a diagnostic test. Kuhn et al, recruited consecutive women 
undergoing urodynamics for any lower urinary tract symptoms. They compared vaginal 
(5MHz probe), perineal and abdominal ultrasound measurement of BWT after filling the 
bladder to 50 mls with a catheter. Out of 125 women, 21 were excluded as they had voiding 
dysfunction. This study had a different objective to that of our study, was from a single centre 
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with overlapping patient population, had slightly different method of transvaginal scan, was 
not powered for diagnostic accuracy and BWT was not blinded to urodynamic diagnoses with 
a potential to introduce bias (Kuhn, Genoud, Robinson, Herrmann, Gunthert, Brandner, & 
Raio 2011). 
 
In a prospective study consecutive women with OAB symptoms, SUI and all types of MUI 
who had urodynamics and the transvaginal scan for BWT were recruited. The mean BMI of 
women in their study was lower compared to our study. The technique was slightly different- 
5 m HZ probe and a parasagittal view (as opposed to 7-9 MHz and sagittal view) was used 
for BWT measurement. They concluded that although there is a relationship between BWT 
and DO at higher BWT values beyond 6.5 mm, only 6.5% of their study population would 
have theoretically avoided urodynamics (Serati, Salvatore, Cattoni, Soligo, Cromi, & Ghezzi 
2010). Our study is superior to that of Serati et al, with a more selective patient population 
(only the ones with OAB/urgency predominant MUI), larger sample size based on power 
calculation, assessment of inter-observer variation, multicentre recruitment, and prospectively 
determined sensitivity analysis. 
 
Estimates of diagnostic accuracy of the index test are directly influenced by the quality, the 
reliability and the reproducibility of the reference standard and the level of agreement 
between the index test and the reference standard(Lijmer, Mol, Heisterkamp, Bonsel, Prins, 
van der Meulen, & Bossuyt 1999). Estimates of the sensitivity and specificity or area under 
the curve (AUC) for new diagnostic tests are difficult to produce when the accuracy of the 
reference standard is unknown, or known to be imperfect. Many studies have cast doubt on the 
reproducibility and accuracy of urodynamics, which is our reference standard. During 
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evaluation of reproducibilty of urodynamics in healthy volunteers and patients with OAB, 
inconsistencies between serial urodynamic procedures were a common finding (Bellucci et al. 
2012;Broekhuis et al. 2010;Brostrom et al. 2002;Digesu et al. 2003b). In a multicentre study 
with six serial urodynamics in patients with OAB, there was increased variability in pressure 
measurements than volume measurements (Frenkl et al. 2011). 
 
When estimating the test accuracy of BWT against an imperfect reference standard 
urodynamics, the accuracy of BWT may have been biased to an unknown degree, or 
submerged in the ‘noise’ from the imperfect reference standard. However, the poor accuracy 
for BWT elicited in our study is likely to be related to inherent inaccuracy of BWT since 
there was no significant relationship between bladder wall measurements and grades of DO 
severity. When the test (BWT) values do not differ amongst those with varying grades of the 
target condition, it can be inferred that the lack of accuracy may be an inherent feature of the 
index test. 
4.83 Interpretation of findings 
A key difference between the BUS study and all others is the focus on the accuracy of 
ultrasound in a group of women with OAB/Urgency predominant mixed incontinence and 
who do not have signs of pure stress urinary incontinence (SUI). The prevalence of DO in 
women with OAB, urgency predominant mixed incontinence was found to be 60%, which 
was similar to other studies. When exploratory analyses was performed comparing women 
with isolated DO to those of mixed urodynamic incontinence of DO and USI, there was no 
change in our findings. Even in women with an incompetent sphincter (DO co-existing with 
USI), the BWT was very similar to those with a competent sphincter. This finding disproves 
the theory that bladder wall hypertrophies and thickens when it contracts against a closed 
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sphincter (Khullar, Salvatore, Cardozo, Bourne, Abbott, & Kelleher 1994;Khullar, Cardozo, 
Salvatore, & Hill 1996). 
 
There is some emerging evidence from observational studies that the response to invasive 
therapies might be similar in patients with frequency and urgency +/- urgency incontinence, 
with or without the observation of DO on urodynamics. An adequately powered multicentre 
RCT of urodynamics vs. no urodynamics in patients with OAB receiving invasive therapies 
like PTNS, Botox and SNS would be helpful in discerning its role in OAB. There might be a 
potential in further research into the diagnostic accuracy of the ICIQ-OAB questionnaire. 
4.9 Conclusion 
Given the poor performance for BWT as tool for diagnosing DO, the recommendation for 
clinicians is to not use it as an alternative to urodynamics. There is no further role of BWT in 
women with OAB.  
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Chapter 5: Interobserver variability in the sonographic assessment of 
bladder wall thickness 
Introduction 
Validation of a test will involve the scientific community define a threshold, and then gather 
sufficient information to allow test to be used with confidence. A minimum standard of 
reliability and reproducibility need to be met for any diagnostic test as limited or poor 
reproducibility affects the precision of a test (Bossuyt et al. 2003). Agreement between 
different clinicians performing the test depends on the ease of interpretation. If the people 
who actually perform and interpret the test cannot agree on the interpretation, the test results 
will be of little clinical use. 
 
Inter-observer reproducibility of BWT can be demonstrated by studying the difference 
between blinded observers when exposing the same patient to the technique independently at 
different points of time. Reproducibility of BWT is of particular importance given the fact 
that bladder is distensible organ and its thickness is known to change with the amount of 
urine present in the bladder. The aim of this study was to assess whether measurement of 
BWT using transvaginal ultrasound have adequate reliability and reproducibility to detect 
difference in BWT potentially indicative of DO.  
5.1 Objectives 
The three key objectives were:  
1) To estimate the intra-observer measurement error in interpreting images by comparing 
blinded duplicate assessments of images by a single observer  
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2) To estimate the inter-observer measurement error in interpreting images by comparing 
blinded duplicate assessments of images by different observers  
3) To estimate the inter-observer measurement error in the complete scanning and 
interpretation process by comparing measurements made by different observers on different 
scans made on women at two separate occasions.  
5.2 Methods 
The reproducibility study was carried out as a part of the multicentre Accuracy of bladder 
wall thickness ultrasound in the diagnosis of Detrusor Overactivity (BUS study) which was 
approved by Nottingham Research Ethics Committee (ethics no10/H0408/57) and funded by 
the National Institute of Health Research/ Health Technology Assessment Board. BUS study 
was aimed at evaluating whether BWT measurement could reduce the need for urodynamics 
in women with OAB.  
 
When a second observer was available, women who agreed to have two transvaginal scans by 
different operators were recruited into the study evaluating the prospective reproducibility of 
BWT scans. Recruitment into interobserver studies was opportunistic based on the 
availability of a second observer and patients who were willing to have a second scan. For the 
studies evaluating the reproducibility of the interpretation of scans, random selections of 
images were sent by the recruiting centres at the request of the trial coordinator.  
 
Measurements of BWT at the trigone, dome midline and anterior wall midline were made as 
per a standardised operating procedure using 2-D transvaginal end firing probe, as shown in 
Figures 1 and 7. The BWT measurement was defined as the mean of three measurements 
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made at the locations ([trigone+dome midline+anterior wall midline]/3). The process of 
measurement required placing a calliper reference point on the image, using a mouse 
operated cursor on the electronic image, at the interface between the bladder wall and the 
adjacent tissue or lumen (Figures 1 and 7). Images were saved with and without the calliper 
placement.  
 
Three sub-studies were undertaken to address the three above mentioned objectives;  
In sub-study A, BWT was measured on 37 ultrasound images from individual participants. 
Repeat measurements were made by the same observer on the same images 6-12 months 
later. All second measurements were made blind to the original measurement, using images 
without calliper marks. All images were from the Birmingham Women’s Hospital, and were 
measured on the scan machine. The measurement process was the same from the beginning 
to the end of the study and included repeat measurements. All measurements complied with 
our standard operating procedure.  
 
In sub-study B, BWT was measured on ultrasound images from 57 individual participants by 
a single observer. Repeated measurements were made by one of 8 different observers on the 
same images, such that there were duplicate measures for each image (Table 12). All second 
measurements were made blind to the original measurement, using images without calliper 
marks. Images from the Birmingham Women’s Hospital were measured on the scan machine; 
those performed outside BWH were measured using Digital Imaging and Communications in 
Medicine (DICOM) software. 
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In sub-study C, 27 women underwent two separate ultrasound scans at different points of 
time undertaken by different observers. The second scans and measurements of BWT were 
made blind to measurement from the first observer. Three observers were used in total, all 
women received scans from observer one, followed by either observer two or observer three 
(Table 12). Details of experience of the operators in the reproducibility study have been 
elucidated in table 13. The previous evidence on the reproducibility of BWT has been 
summarised in table 15. 
5.3 Analyses 
For each study BWT measurements were analysed using one-way analysis of variance. One-
way ANOVA decomposes the total variation observed (𝑆𝑆𝑇2 ) into that originating from 
differences between women (𝑆𝑆𝐼2 - individual variability) and that caused by the 
measurement process (𝑆𝑆𝐴2 - analytical variability). The estimates are linked as 𝑆𝑆𝑇 =
�𝑆𝑆𝐴
2 + 𝑆𝑆𝐼2. The standard deviation for analytical variability, 𝑆𝑆𝐴  estimates the 
measurement error.  
 
Two further statistics were computed from these values. The intraclass correlation coefficient 
(ICC) described the fraction of the total variance in BWT measurements due to individual 
rather than analytical variation (𝑆𝑆𝐼2/𝑆𝑆𝑇2 ). ICC values lie between zero and one: 
measurements that are reliable have ICCs approaching one, as the signals (the individual 
variation) dominate the noise (the analytical variation). 
 
The repeatability coefficient described the smallest real difference (SRD) that can be detected 
with a specified degree of certainty between two measurements, and was computed as 
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√2Z�SDA2  (where Z takes the value of 1.96 for a difference which has 95% certainty of being 
a real effect and not measurement error). SRD values were given in the units of the original 
measurement. The above analyses were all undertaken assuming exchangeability of 
observers, i.e. that the ordering of the measurements has no relevance. Generalizability of 
these findings relies on the observers being presumed to be representative of those who 
would make the measurements in practice. 
 
The data in scatterplots and Bland-Altman plots was to demonstrate the distribution of 
measurements and differences between measurements. For these analyses assignment of 
measurements to particular observers is important. In sub-study A there is a logical choice for 
the first and second measurements, and the distribution of these differences is of interest. In 
sub-studies B and C measurements made by observer 1 were arbitrarily taken as the first 
measurement and remaining observers 2 through 6 were taken as the second measurement. 
5.4 Results  
A total of 121 women were invited and all of them took part in the sub-studies. The 
distribution of BWT measures are shown in Table 12. The mean and standard deviation of the 
BWT measures in each sub-study were similar to that of the BUS cohort. Ranges in the sub-
studies were lower, which is expected as ranges increase with sample size.  
5.41 Sub-study A - Intra-observer repeatability of the same scans 
Paired measurements were available for 37 women. The scatter of measurements is shown in 
Figure 14, and the distribution of differences in measurements in Figure 15.The later 
measurements were on average higher than the earlier measurements by 0.35mm, 95%CI: 
0.19 to 0.51 (p<0.0001) but without any evidence of a relationship between error and the 
mean BWT value. Differences in measurements of up to 1.5mm were observed. 
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The standard deviation for the analytical variation for intra-observer variability was estimated 
as 0.42mm (Table 14).This level of variability compares to a standard deviation of 1.04mm 
between individual differences, thus 86% of the total variability observed is attributed to 
individual variability and 14% to measurement error. With this level of measurement error, 
differences of over 1.16 mm are 95% likely to be real for this single assessor. 
Figure 14: Scatter plot for sub-study A- Intra-observer repeatability of the same scans 
 
Figure 15: Bland-Altman analysis for sub-study A  
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5.42 Sub-study B Inter-observer repeatability of the same scans 
Paired assessments were available for 57 women made by one of the 8 different observers. 
The distribution of measurements and differences are shown in (Figures 16 & 17). 
Differences as large as 2mm were observed. The standard deviation for the analytical 
variation for inter-observer variability was estimated as 0.35mm (Table 14).This level of 
variability compares to a standard deviation of 1.23mm between individuals, thus 93% of the 
total variability observed is attributed to individual variability and 7% to measurement error. 
With this level of measurement error, differences made by assessors similar to these would 
need to be at least 0.97 mm to be 95% likely to be real.  
Figure 16: Scatter plot for sub-study B-Inter-observer repeatability of the same scans 
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Figure 17: Bland Altman analysis for sub-study B  
 
5.43 Sub-study C Inter-observer repeatability of different scans 
Paired measurements were made for 27 women prospectively using 3 different observers. 
The design of Study C included estimation of variation occurring from repeated scans 
together with the interpretation of scans. The distribution of measurements is shown in 
(Figure 18), and of differences in (Figure 19).Maximum differences were again around 2mm, 
but they were more common in this sub-study than in previous sub-studies A and B. 
Figure 18: Scatter plot for sub-study C- Inter-observer repeatability of different scans 
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Figure 19: Bland-Altman analysis for sub-study C  
 
The standard deviation for the analytical variation for intra-observer variability of repeated 
scans was estimated as 0.76mm (Table 14). This level of variability compares to a standard 
deviation of 0.95mm between individuals, thus 61% of the total variability observed is 
attributed to individual variability and 39% to measurement error. With this level of 
measurement error, differences made by assessors similar to these would need to be at least 
2.11 mm to be 95% likely to be real. 
Table 12: Comparison of distribution of BWT measures between the full BUS study and the sub-
studies 
Study Observer Bladder wall thickness (mm) 
  N Mean  SD range 
BUS Multi-centre study 645 4.78 1.34 1.07-9.60 
Sub-study A 
Observer 1 37 5.60 1.14 3.40-7.73 
Observer 2 37 5.95 1.08 4.00-8.03 
Sub-study B 
Observer 1 57 5.05 1.30 2.10-7.53 
Observers 2-6 57 5.07 1.26 2.27-7.33 
Sub-study C 
Observer 1 27 4.86 1.04 2.77-7.17 
Observers 2-3 27 4.73 1.38 1.83-7.43 
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Table 13: Details the experience of the observers in the sub studies 
Study  Observer and location ‘Skill level’ (years of experience in O & G) 
Sub-study A Observer 1: Birmingham (n=37 x 2); 15  
Sub-study B Observer 1: Birmingham (n=57) 15  
Observer 2: Birmingham (n=34) 10  
Observer 3: Birmingham (n=4) 5  
Observers 4-6 Bournemouth (n=7); St 
Mary’s (n=4); Medway (n=8); 
7-20  
Sub-study C Observer 1: Birmingham (n=27) 15  
Observer 2: Birmingham (n=16) 15 
Observer 3: Birmingham  (n=11) 10  
 
Table 14: Estimates of measures of analytical and individual variability 
Sub-study 
(interpretation) 
Individual 
variability SD 
(mm) 
Analytical 
variability SD 
(mm) 
ICC, 95%CI Smallest real 
difference (mm) 
 
Sub-study A 
(Intra-observer  of 
same scans) 
1.04 0.42 0.86 (0.75, 0.92) 1.16 
Sub-study B 
(Inter-observer  of 
same scans) 
1.23 0.35 0.93 (0.88, 0.96) 0.97 
Sub-study C 
(Inter-observer from 
repeat scans) 
0.95 0.76 0.61 (0.32, 0.80) 2.11 
 
 
5.5 Discussion  
We undertook three separate studies to investigate the reliability and repeatability of 
measurements of BWT using transvaginal ultrasound. For the intra-observer variation study, 
the individual variability in standard deviation (SD) was 1.04mm with an analytical variation 
of 0.42mm.In the inter-observer variation study on interpretation of stored images, we found 
an SD of 1.23mm with an analytical variation of 0.35mm and for the inter-observer variation 
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of repeated scans performed prospectively, the SD was 0.95mm with an analytical variability 
of 0.76mm (Table 14). 
 
Our analyses have found that differences of less than 2mm in BWT cannot be safely 
interpreted as indicating real differences in BWT, as such differences are in the realms of 
those attributable to analytical variability (measurement error).We observed that the process 
of interpreting scans introduces measurement error of around 1mm, suggesting that the 
remaining 1mm is attributable to a combination of the scanning process and biological 
variability. The sub-studies were also designed to identify the magnitude of the possible 
sources of the analytical variability. 
 
We failed to assess whether the differences in interpreting the scans arise because of within 
or between observer variability. Surprisingly our estimate of intra-observer variation is 
greater than that of inter observer variation. As the study samples are not large, and different 
scans were assessed for these repeat measurements, this observation potentially could be 
explicable by the play of chance or confounding. However, problems were also experienced 
with the quality of stored images used in sub-study A and B from the Birmingham Women’s 
hospital which were not saved using DICOM software. The deteriorating quality of stored 
images may have resulted in measurements on stored images slightly greater than real time 
measurements and explain the finding that second reads of scans in sub-study A on average 
gave BWT measures 0.6mm greater than the original measurement. 
5.51 Findings in the context of existing evidence 
Six previous studies of reliability and reproducibility of BWT have used a variety of 
ultrasound techniques including transabdominal (Kuo 2009;Pannek, Bartel, Gocking, & 
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Frotzler 2012) and translabial (Lekskulchai & Dietz 2008) as well as transvaginal scanning 
(Chung, Liao, Chen, & Kuo 2011;Khullar, Salvatore, Cardozo, Bourne, Abbott, & Kelleher 
1994;Panayi et al. 2010b;Tubaro A  et al. 2013) as summarised in (Table 15). Several of 
these studies investigated women with different or a mixture of LUTS, or used varying levels 
of bladder filling. Of the transvaginal ultrasound studies only two (Kuo 2009;Panayi, Khullar, 
Fernando, & Tekkis 2010a) included assessment of repeated scans carried out at different 
points of time as in our third sub-study, evaluating 10 and 25 women respectively. The other 
two studies (Khullar, Salvatore, Cardozo, Bourne, Abbott, & Kelleher 1994;Tubaro A et al. 
2013) evaluated the reproducibility of image interpretation (as in our first and second sub-
studies) based on repeated assessment of 10 and 1544 images respectively. 
 
Comparison of findings between these previous studies and the BUS study is complicated 
due to inappropriate use of Bland-Altman analyses and Pearson’s correlation coefficients. 
Neither of these methods directly estimated the degree of analytical variability allowing 
assessment of the reproducibility of the measurement and the signal to noise ratio, although a 
pseudo estimate of analytical variability can be computed from the standard deviation of the 
differences. Reporting of the study design and statistical analysis was often incomplete or 
ambiguous. (Table 15) (Panayi, Khullar, Fernando, & Tekkis 2010a;Tubaro A, Khullar V, 
Oelke, Wijkstra H, Tretter R, Stow B, Huang M, Compion G, & Robinson D 2013). 
Estimates of the standard deviation of analytical variability vary between 0.3mm and 1.3mm 
for inter- and intra-observer variation for image interpretation (compared to 0.3-0.4mm for 
the BUS study), and a standard deviation of 0.4mm for inter-observer variation for repeated 
scans (compared to 0.8 mm for the BUS study). Kuo et al only reported Pearson’s correlation 
coefficients from which no useful measures of reproducibility can be obtained (Kuo 2009). 
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5.52 Strengths and limitations of the study 
The women reported to our study were recruited prospectively as part of the BUS test 
accuracy study, which involved good characterisation of symptoms and disease state. They 
were recruited from standard NHS incontinence clinics, and are thus highly likely to be 
representative of women in whom BWT would be measured as part of the diagnosis of DO.  
The sub-samples in each study appear to be representative of the larger cohort. BWT 
measurements were made according to a standardised protocol implemented following a 
programme of rigorous investigator training implemented in the larger study, which will have 
minimised variability due to differences in technique. 
 
Both the number of women and the number of assessors limit the precision of the estimates 
made, although the study was larger than many previously undertaken. The assessors who 
partook in the intra observer studies generally had high levels of experience and expertise 
with the techniques, such that the estimates of operator dependent analytical variability may 
be lower than those in standard practice (Table 13).  
 
In sub-studies A and B, the use of stored images of the original bladder transvaginal scan was 
problematic because those not stored using DICOM software were of poorer quality than the 
original images, as reported in previous inter-observer variation studies using ultrasound 
(Amer et al. 2002). We found that the brightness of echogenic serosa and mucosa were 
reduced in the stored ultrasound images, making the bladder wall less distinct and reducing 
the ability to place the calipers accurately. This may have led to over-estimation in analytical 
variation in sub-studies A and B, particularly in A, where no images were stored using  
DICOM. 
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The site of measurement is important. At the dome of the bladder, the peritoneal reflection 
may add 1 mm to the apparent wall thickness (Jequier and Rousseau 1987).Visualizing and 
measuring anterior part of the bladder wall can be challenging in patients with cystocele and 
those who have undergone bladder-neck surgery. Even in patients with normal anatomy, it 
may be difficult to see the anterior bladder wall because of the ring-down artefact of the 
anterior abdominal wall and the shading by the acoustic shadow from the pubic symphysis 
(Yang and Huang 2003). Sometimes, the bladder outline may be irregular and undulating and 
the margins may not be seen clearly resulting in significant variation in thickness 
measurements of stored scan images. The normal bladder is indented by surrounding organs 
(bowel, uterus). 
 
Depending on how the surrounding structures were indenting the bladder, sometimes the 
image may show the cross-section of the bladder wall perpendicularly and sometimes 
tangentially. In addition, the variable shape of the bladder with different degrees of filling 
may result in errors in calculating bladder volume (Rachaneni et al. 2013a). These variables 
in BWT measurement may explain the difference in prospective measurements of BWT (sub-
study C). 
5.53 Interpretation  
Ultrasound measurements of BWT have a high level of analytical variation arising from the 
scanning technique, underlying biological variability and interpretation of images, such that 
only differences greater than 2mm should be interpreted as indicating real changes in BWT.  
The range of BWT measurements observed in the full cohort ranged from 1mm to 10mm.To 
illustrate the potential impact of measurement error of this magnitude, if a threshold of 5mm 
is used to define test positives, those between 3 and 5mm could be mis-classified as test 
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negatives through measurement error, and those between 5 and 7mm be misclassified as test 
positives. In the BUS cohort of 645 women, 326 had values between 3mm and <5mm, and 
217 had values between 5mm and <7mm. These groups constitute 84% of the complete 
sample. Only 41 women (6%) had BWT measures of 7mm and over, and 61 (10%) have 
measurements less than 3mm.Thus for the majority of women included in the study there is a 
possibility that a transvaginal ultrasound measurement of BWT would misclassify them using 
a 5mm threshold due to analytical variation. Rates of potential misclassification for higher or 
lower thresholds would be lower, but still substantial. 
5.6 Conclusion 
In the presence of high levels of analytical variation (measurement error) for a relatively 
small measurement of BWT, it is unlikely that BWT measurement by transvaginal ultrasound 
has sufficient reliability and reproducibility to be an accurate diagnostic test. 
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Table 15: Pre-existing evidence on inter and intra-observer variation of BWT  
Study Patients and study 
design 
Technique  and 
route of scan 
Results presented Comment on results 
Khullar 1994 
Ultrasound 
Journal of 
Obstetrics and 
Gynaecology 
10 women each 
received one scan 
which was interpreted 
twice by each of two 
readers 
 
Transvaginal BWT Intraobserver difference 
-0.02mm 95%CI* (-
0.22,0.18) 
Interobserver difference 
0.02mm 95%CI*  (-
0.32, 0.35) 
*paper states that the CI 
is computed as  
2 standard 
deviations(SD) either 
side of the mean, not 
2SE. 
Not possible to 
ascertain the 
analytical variability,  
the smallest real 
difference or the 
intra-class correlation 
coefficient from the 
data presented.  
An approximate 
(under) estimate of 
the analytical 
 variability can be 
obtained by dividing 
the SD of the 
differences by √2, i.e. 
0.3mm for intra and 
0.5mm for inter 
observers 
Lekskulchai 
2008 
Ultrasound 
journal of 
Obstetrics and 
gynaecology 
67 women each had 
one scan read once by 
two different readers  
Translabial 
DWT at dome 
Intraclass correlation 
coefficient estimate of 
ICC=0.82;  
95%CI (0.63–0.91) 
No estimates of 
analytical variability 
or smallest real 
difference can be 
computed. 
Kuo 2009 
IUJ 
10 women each 
received two scans two 
weeks apart 
Transvaginal and 
transabdominal 
DWT 
measurement 
Pearson’s correlation 
coefficients are reported 
for transvaginal 
measures: 
Bladder base- 0.833 
(p=0.020), Anterior 
wall- 0.759 (p=0.05) 
Posterior wall-0.599 
(p=0.155) Bladder 
neck-0.768 (p=0.044) 
No estimates of 
analytical variability, 
smallest real 
difference or 
intraclass correlation 
coefficients can be 
computed. 
Panayi 2010 
BJUI 
25 women each had 
two scans by two 
different operators on 
the same day. 
Transvaginal BWT 
at Dome, Anterior 
wall, and Trigone 
Mean difference and 
95% confidence 
interval for the three 
locations are: 
0.13mm (0.08–0.33) 
0.10mm (−0.12–0.31) 
−0.22mm (−0.41–0.01) 
Not possible to 
ascertain the 
analytical variability, 
the smallest real 
difference or the 
intraclass correlation 
 coefficient from the 
data presented.  
An approximate 
(under) estimate of 
the analytical 
variability  
can be obtained by 
dividing the sd of 
differences by √2, 
 i.e. 0.4mm for all 
three measures. 
Pannek 2013 
World Journal 
10 women had two 
measurements made by 
Transabdominal 
DWT at three 
States that interobserver 
coefficient of variability 
The mean DWT is 
not reported in the 
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*DWT- detrusor wall thickness; sd- standard deviation 
 
 
 
 
 
 
 
of Urology the same observer (and 
implies these were 
from different scans 
which were repeated 
immediately)  
different sites of 
the bladder 
was +14.78%, and the 
correlation (not stated 
whether Pearson’s or 
ICC) was 0.984.   
paper, thus it is not 
possible to deduce the 
analytical variability, 
the smallest real 
difference and the 
ICC. 
Tubaro 2013 
ICS abstract 
136 
40 women each had 
one scan which was 
interpreted twice by 
each of three readers 
A further 1504 images 
were assessed twice by 
different readers 
 
Transvaginal BWT Data were analyzed 
using the Bland-Altman 
method, and mean 
differences and 
confidence intervals 
within and between 
readers presented  
Standard deviations of 
differences between 
pairs of readers were 
1.1mm, 1.7mm and 
1.8mm. 
Not possible to 
ascertain the 
analytical variability, 
the smallest real 
difference or the 
intraclass correlation 
coefficient from the 
data presented.  
An approximate 
(under) estimate of 
the analytical 
variability can be  
obtained by dividing 
the sd of differences 
 by √2, i.e. 0.8 to 
1.3mm 
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Chapter 6: Evaluation of patient acceptability of Bladder Ultrasound 
(BUS) and Urodynamics   
Introduction 
In this chapter a comparative evaluation of the acceptability of performing both transvaginal 
bladder ultrasound scanning to measure BWT and urodynamics from the patient’s 
perspective was undertaken.  
6.1 Methods 
Participants (n=687) were the patients who took part in the BWT diagnostic accuracy study 
(details given in Chapters on methods and Results).They underwent BWT scan and 
urodynamics in the participating centres, where possible, carried out on the same day. If it 
was not possible for both the tests to be performed on the same day, they were completed 
within a four week period. Immediately after each test, acceptability questionnaires were 
given to the participant for completion. Items included in the questionnaire were as follows: 
 
Pain measured using a Visual Analogue Scale (VAS) on a 0 (no recorded pain) to 100 (worst 
pain imaginable) scale during and shortly after testing (Jensen et al. 2003;Price et al. 1983). 
 
Acceptability of testing is measured by STAI-SF (six item) to measure generic state anxiety. 
This is a validated and widely accepted instrument used to assess the intensity of current 
feelings in relation to how you “generally feel today” (Marteau and Bekker 1992). Scores 
ranged from 4 (most positive) to 24 (most negative). The short form was used to improve 
patient compliance as opposed to the long form to accommodate time constraints in busy 
clinics.  
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All responses were compared using paired (urodynamics versus BWT scan) methods for 
dependant data (Agresti A 2011). For VAS and STAI-SF scores, mean differences and 95% 
confidence intervals were calculated with statistical significance determined by a paired t-
test. Wilcoxon signed-rank test was used for ordinal responses and McNemar’s test for binary 
responses. Analysis was performed using SAS software, version 9.2 (SAS Institute).  
6.2 Results  
6.21 Pain during and after the tests 
Pain scores during urodynamics testing (28.1 points) and shortly after (21.1) were higher than 
the corresponding scores during BWT scan (15.3 points) and after BWT scan (13.3 points) 
respectively (Table 16).  
Table 16: Pain during after the urodynamics and bladder ultrasound tests 
 Urodynamics  
Mean(SD, n) 
Ultrasound 
Mean (SD, n) 
Difference 
95% CI 
p-value 
During 28.1 (28.4, 653) 12.8 (19.5, 646) 15.3 (13.1 to 17.6) <0.001 
After 21.1 (26.7, 648) 7.9 (16.1, 646) 13.3 (11.2 to 15.4) <0.001 
 
6.22 Acceptability  
The proportion of women who found the test totally acceptable was higher with BWT scan 
compared with urodynamics (81% versus 56%; p<0.001), although the number reporting an 
unacceptable test was still relatively low following urodynamics (2%). (Table 17) More 
women found the exposure required for the test embarrassing with urodynamics compared 
with BWT scan (proportion reporting some embarrassment 64% v 48%; p<0.001).Fewer 
women felt that they would recommend urodynamics to a friend compared to BWT scan 
(86% v 96%; p<0.001) and have the same test again (88% v 97%, p<0.001). 
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Table 17: Acceptability of urodynamics and transvaginal bladder ultrasound tests 
  Urodynamics  (n= 
653) 
Frequency (%) 
Ultrasound (n= 648) 
Frequency (%) 
p-value 
Procedure 
acceptability 
Totally 368 (56%) 521 (81%)  
Generally 273 (42%) 124 (19%) <0.001 
Unacceptable 12 (2%) 1 (<1%)  
Exposure for test 
embarrassing? 
Extremely 55 (8%) 21 (3%) 
<0.001 
Moderately 128 (20%) 63 (10%) 
A little 237 (36%) 230 (35%) 
No 233 (36%) 334 (52%) 
Recommend test to 
a friend? 
Yes 559 (86%) 625 (96%) 
<0.001 
No 93 (14%) 23 (4%) 
Have same test 
again? 
Yes 572 (88%) 627 (97%) 
<0.001 
No 78 (12%) 20 (3%) 
 
6.23 Anxiety 
Anxiety levels associated with both tests appeared quite moderate (12.6 for BWT scan and 
12.9 for urodynamics), although the scores were only slightly higher with urodynamics (0.3 
points difference on a 4-24 scale, 95%CI: 0.1 to 0.5; p=0.02). (Table 18) 
Table 18: STAI-SF 
Urodynamics 
Mean (SD, n) 
Ultrasound 
Mean (SD, n) 
Difference (95%CI) p-value 
12.9 (3.8, 616) 12.6 (3.8, 602) 0.3 (0.1 to 0.5) 0.02 
 
6.3 Discussion 
Results show that BWT scan was more acceptable and less embarrassing and painful than  
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urodynamics. Despite this, a high proportion of women said that would recommend the 
urodynamics test to a friend (88%) and also have it repeated (86%). Anxiety scores were also 
higher for- urodynamics compared to BWT scan, though the mean difference was small. To 
our knowledge this is the first formal evaluation of the comparison of tolerability and 
acceptability of various diagnostic procedures to evaluate bladder function.  
 
The question is whether urodynamics are likely to be deemed acceptable in terms of having 
them repeated in view of its clinical importance. Women were aware that their treatment 
plans were based on the urodynamics diagnoses and not that of BWT scan. This awareness of 
importance may have contributed to the improved acceptability of having this test repeated 
again if necessary. I have enclosed a comment made by one of our patients with regards to 
acceptability of urodynamics: 
‘Although BWT scan was a generally more acceptable test, I felt that because urodynamics 
physically replicated my symptoms, it allowed me a better understanding of my condition.’ 
Pain was higher with urodynamics although the average score was 28 on a scale of 0-100. 
Origin of pain may be multifactorial. Pain could be due to physical components like the 
urethral and rectal catheterisation and the artificial filling of the bladder. Following 
urodynamics, participants often expressed urethral pain. The exact mechanism of pain 
perception after the urodynamics is not known though slight trauma to the urethra may be 
considered to be an aetiological factor (Gorton and Stanton 1999).  
 
Elevated anxiety levels during urodynamics may also have contributed to patient’s perception 
of pain. Women are worried about going through invasive procedures and the perception of 
pain or discomfort associated with them(Marteau & Bekker 1992). Fear of perceiving pain 
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may increase the anxiety levels in patients going through dental and minor surgical 
procedures(Terry et al. 2007). The perception of pain and discomfort from invasive 
procedures may be worsened by pre-existing fear of pain (Bradley and Kennedy 2008).Fear 
of pain may increase the background anxiety levels (McNeil and Berryman 1989) and may 
influence their willingness towards invasive testing and follow-ups (Denberg et al. 2005). 
The level of apprehension and embarrassment during urodynamics had a positive correlation 
to the level of pain perception. Younger age and the fear of undergoing an invasive procedure 
were found to be the risk factors for the heightened perception of pain (Yiou et al. 2013).  
 
Results on pain/anxiety and embarrassment provoked are similar to those mentioned in the 
literature. In a prospective study of 208 patients, although urodynamics was only associated 
with minor complications, it was perceived to be painful, (pain score of 3.1/10) worrying and 
traumatic (Ku et al. 2004). In a study of pre-test and post-test evaluation of anxiety with 
urodynamics, severe pre-test anxiety was reported in only a small fraction of women (4.6%) 
undergoing urodynamics. Following completion of urodynamics, women reported minimal or 
no anxiety(77.5%), minimal or no embarrassment (84.1%) and minimal or no physical 
discomfort (75.5%) (Neustaedter et al. 2011). Younger age, history of anxiety or depression, 
a diagnosis of OAB and painful bladder syndrome may lead to more negative experiences 
during urodynamics (Yeung, Eschenbacher, & Pauls 2014).  
6.31 Strengths and Limitations  
A strong component of the study was that a large number of patients were recruited (n=687) 
and comprised of a population derived from several geographical areas and various 
ethnicities within the UK. Data collected from multicentre studies may be more applicable 
and generalizable than that collected from a single centre. The study provides information to 
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assist in counselling women who may be apprehensive or anxious regarding an invasive test 
such as urodynamics.  
 
The instrument to measure anxiety was administered only after each test procedure. The 
difference between pre and post-test questionnaires to know the anxiety provoked by each 
procedure should have been measured. This would have yielded valid data about fluctuations 
in anxiety state before and after each test and a comparison of the difference would have been 
ideal.  
 
Participants were aware of the fact that the diagnoses and the plan of management were made 
on the basis the information gained during urodynamics. The awareness of the role of the test 
in clinical decision making may have introduced bias and influenced the participant’s 
decision to recommend the test or have it repeated again if required. Participants were aware 
that the BWT scan was used for assessment only and did not aid in the management of a 
bladder diagnosis. 
 
Compared to patients with low trait anxiety scores, patients with higher trait anxiety will 
experience increased anxiety with invasive procedures(Spielberger,1983). Anxious women 
have increased episodes of urgency incontinence and vice versa. High anxiety score on the 
STAI was a predisposing factor for UI (Marteau & Bekker 1992). UI may increase anxiety of 
possible social exclusion in the geriatric population(Agresti A 2011).Logically, women with 
higher trait anxiety levels should experience greater state anxiety to urodynamics compared 
to BWT scan. Unfortunately, the Trait anxiety was not studied due to time constraints in our 
busy clinics. 
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The impact of the information given to the women before the procedure and how well we 
prepared the women for each diagnostic test was not studied. The information leaflets about 
both urodynamics and BWT scan procedures were sent out along with the appointment 
letters. During the clinic visit, the patient’s understanding of each procedure was further 
reinforced. This was our routine practice based on the previous evidence that women were 
likely to find the test less distressing when they knew what to expect during the course of the 
investigation(Gorton & Stanton 1999). 
6.32 Interpretation of findings 
Urodynamics procedure had statistically significant higher levels of pain and a lower rate of 
acceptability compared to the ultrasound. Inspite of this, majority of women would have 
repeat urodynamics if needed. The results of this study will help in the preparation of 
information leaflets for women on urodynamics and/or transvaginal ultrasound, to get a 
realistic picture of patient experience of these invasive investigations. 
6.4 Conclusion 
The elevated anxiety levels elicited by invasive diagnostic testing on a background of 
increased trait anxiety due to lower urinary tract symptoms need careful evaluation and 
interpretation. This evidence may improve the support women receive during invasive 
diagnostic testing (urodynamic testing) and their subsequent satisfaction.  
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Chapter 7: Discussion 
7.1 Introduction 
Sometimes diagnostic tests are applied in clinical practice without proper evaluation of their 
test accuracy. Revision of formal probability of a diagnosis with the availability of a test 
result is essential to decision making. Clinicians seem to use the pre-test probability of DO 
and formally revise the diagnosis after urodynamics despite the absence of evidence of 
quantitative accuracy of urodynamic test. 
 
Three distinct studies have been completed as part of the BUS trial: 
1. To determine the accuracy (sensitivity, specificity, predictive values, ROC curves, AUC) 
of transvaginal BWT as the index test and urodynamics as the reference standard in women 
with OAB 
2. To determine the reproducibility of the index test BWT  
3. To determine the acceptability of BWT and compare it with urodynamics acceptability  
This chapter attempts to focus on the key findings and limitations emerging from the BUS 
study.  
7.2 Evaluation of diagnostic tests  
There was no evidence that BWT had any relationship with DO, regardless of the cut-off 
point (AUC: 0.53, 95% CI: 0.48, 0.57) (Figure: 12). On univariate analyses of the effect of 
various risk factors for predicting DO(Appendix:5.2), age, BMI, ethnicity, history of mixed 
incontinence and history of onset of the type of incontinence ( SUI first or urgency 
incontinence first),parity, menopausal status, voiding difficulties, previous history of POP or 
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incontinence surgery and previous treatment with antimuscarinics were analysed. Only one 
variable-previous history of treatment with antimuscarinics seems to have attained statistical 
significance with a p-value of 0.0005, with an OR and 95% CI of 1.84 (1.30, 2.59). This 
finding could be interpreted as women were appropriately referred to secondary care (NICE 
CG 171) after a failed trial of antimuscarinics and are probably in the more severe spectrum 
of the disease. 
 
The effect of different variables in the diagnostic accuracy of BWT in DO were also studied 
as follows: When a history of urgency alone was considered excluding a history of mixed 
incontinence, the AUC was 0.528(Appendix: 4.1);When the urodynamic diagnosis of isolated 
DO was considered after excluding women with urodynamic diagnoses of mixed DO and 
USI, AUC was only 0.521, 95%CI: (0.476, 0.566) (p=0.37 compared to AUC=0.50) 
(Appendix: 4.2) Similar results were obtained in women with wet DO on urodynamics. The 
AUC was only 0.548, 95%CI: (0.502, 0.594) (p=0.04 compared to AUC=0.50) (Appendix: 
4.3). None of these variables seemed to have had any effect on the diagnostic accuracy of 
BWT.  
 
I undertook three separate studies to investigate the intra- and inter-observer variation of 
BWT using transvaginal ultrasound and concluded that it was unlikely that this measurement 
would be sufficiently reliable or reproducible to be an accurate diagnostic test. Only 
differences greater than 2mm could be safely interpreted as real change in BWT meaning that 
for the vast majority of women (84%) there could be some possibility of misclassification 
when using a cut-off of 5mm.  
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Transvaginal ultrasound was more acceptable as well as less painful than urodynamics. 
Surprisingly, a high proportion of women said that they would recommend the urodynamics 
test to a friend (88%) and also have it repeated (86%).  
7.3 Strengths and limitations 
The methodologically robust test accuracy study design and appropriate conduct of the study 
increase the confidence in the estimates of diagnostic accuracy of BWT. All the criteria for a 
high-quality test accuracy evaluation, the STARD checklist (Bossuyt, Reitsma, Bruns, 
Gatsonis, Glasziou, Irwig, Lijmer, Moher, Rennie, & de Vet 2003) have been met 
(Appendix:1) The study population included only a specific group of women with urgency 
predominant mixed incontinence/OAB compared to all other studies(Kuhn, Genoud, 
Robinson, Herrmann, Gunthert, Brandner, & Raio 2011;Lekskulchai & Dietz 2008) where 
BWT was studied in women with all types of LUTS. There was a very high proportion of 
index test verification by reference standard; over 93% (644/687) ensuring a near complete 
verification design. The strengths also include recruitment of a large sample of 687 women in 
excess of  the target sample size of 600, multicentre setting, prospective and consecutive 
recruitment. Study population were generalizable across the NHS with varying degrees of 
disease severity and a good representation of ethnic mix (22% non-caucasians) (Table: 6). 
The large sample also provided the opportunity to analyse the acceptability of both the index 
test and the reference standard.  
 
Bias in the study methodology was minimised by ensuring that two independent operators 
performed the index tests and reference standard blinded to each other. Standard protocols for 
index and reference standard testing were drawn up and quality assurance checks were made 
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and a pre-specified statistical plan was followed. Comprehensive oversight via an 
independent Data Monitoring/Trial Steering Committee was employed.  
  
The fact that DO was picked up in 60% of the OAB/urgency predominant MUI population 
which was similar to other studies on DO prevalence in OAB (Hashim & Abrams 2006) 
indicate that the study sampling was of the appropriate quality. On evaluation of the 
reproducibility of the index test, BWT, the results were similar to the SHRINK study (Tubaro 
A, Khullar V, Oelke, Wijkstra H, Tretter R, Stow B, Huang M, Compion G, & Robinson D 
2013), which is a retrospective study of centralised measurement of BWT in 1544 patients 
with OAB on antimuscarinics. Though their conclusion was that of good reproducibility of 
BWT, we found significant disagreement between the independent observers on Bland 
Altman’s analysis. There has been no consensus of the acceptable limits of interobserver 
difference in the published literature for BWT measurement. Contrary to the previous studies 
on the reproducibility of BWT measurements, BUS study is the first to analyse prospectively, 
the data on the agreement between the two observers (Bland and Altman 1986). Hence my 
conclusion of lack of reproducibility of BWT may be considered robust. 
 
Studies have utilised Medical, epidemiological and Social aspects of aging questionnaire 
(MESA) sub-scale scores for urgency and stress urinary incontinence. They have categorised 
women who had higher MESA scores for urgency incontinence (compared to their MESA 
subscale scores for SUI) as urgency predominant mixed incontinence along with urogenital 
distress inventory (UDI) scores, bladder diaries and urodynamics (Brubaker, Lukacz, Burgio, 
Zimmern, Norton, Leng, Johnson, Kraus, & Stoddard 2011). We may be criticised for not 
objectively assessing the severity of each type of incontinence before deciding whether the 
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patient suffered from urgency predominant mixed incontinence. In this study, direct patient 
questioning of which is the most bothersome type of incontinence on history taking was 
employed which is a true reflection of routine clinical practice. 
 
The reference standard, urodynamics is known for its uncertain reproducibility. Previous 
studies on the reproducibility of urodynamics in OAB reported inconsistencies between serial 
urodynamic procedures on repeat urodynamics in the same patient (Broekhuis, Kluivers, 
Hendriks, Massolt, Groen, & Vierhout 2010;Homma, Kondo, Takahashi, Kitamura, & 
Kawabe 2000;Mortensen et al. 2002;Sorensen et al. 1984). Repeat urodynamics in the same 
session was poorly reproducible and showed an improved bladder function after the first 
urodynamics. Nearly 50% of the patients had more than ≥25% change in one or more 
variables on repeat urodynamics (Homma, Kondo, Takahashi, Kitamura, & Kawabe 2000). 
Similar findings were reported in another study on healthy volunteers which evaluated repeat 
urodynamics in the same session with an increase in the volume of first and normal desire 
during the second urodynamic procedure(Brostrom, Jennum, & Lose 2002).In a multicentre 
study with six serial urodynamics in patients with OAB, there was increased variability in 
pressure measurements than volume measurements (Frenkl, Railkar, Palcza, Scott, Alon, 
Green, & Schaefer 2011). When repeated in the same session in patients with neurogenic 
LUTS, difference against mean detrusor pressure at maximum flow (Pdet Qmax), voided 
volume and post-void residual urine (PVR) showed wide confidence limits of agreement 
reflecting poor reproducibility and unacceptable discrepancy. However there was excellent 
reproducibility of neurogenic DO in both the tests (κ=0.87, 95% CI 0.80-0.94) (Bellucci, 
Wollner, Gregorini, Birnbock, Kozomara, Mehnert, & Kessler 2012). In a videourodynamic 
study on the reproducibility of voiding flowmetry parameters, high interobserver and 
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intraobserver agreement of Pdet, Qmax , opening detrusor pressure and closing detrusor 
pressure was observed (Digesu, Hutchings, Salvatore, Selvaggi, & Khullar 2003b). The poor 
reproducibility of urodynamics could be due to a combination of variation in the physiology 
of bladder function and the poor sensitivity and specificity of the technology used (Gupta et 
al. 2004). 
 
Having an imperfect gold standard (poor reproducibility of urodynamics) for reference may 
have affected the test accuracy of our index test, the BWT. However, in the absence of 
another reliable diagnostic test for lower urinary tract dysfunction, we have to utilise 
urodynamic test which has been the only available diagnostic test so far. 
 
The study design selection of test accuracy for evaluating the accuracy of BWT in diagnosing 
DO may be questioned. In asymptomatic conditions like cervical premalignant conditions, 
test accuracy statistics of screening and diagnostic test results may have a major role in 
clinical decision making. There is some emerging evidence that making a diagnosis of DO 
does not alter treatment outcomes for interventions including use of antimuscarinics (Malone-
Lee and Al-Buheissi 2009), Botulinum toxin, percutaneous tibial nerve stimulation (PTNS) 
(Vandoninck et al. 2003) and sacral neuromodulation (SNS) (South et al. 2007). This is why 
one may question the role of diagnostic tests in this condition as it might not alter patient 
management.  
 
A randomised controlled trial (RCT) comparing treatment outcomes of women who undergo 
BWT along with office evaluation compared to office evaluation and urodynamics may have 
been a stronger study design. This design could have shed light on the influence of evaluated 
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test on the management and prognosis of the OAB/urgency incontinence patients. 
Nevertheless, the study designs selected depend on the preexisting evidence.  
7.4 Performance of other biomarkers for DO 
Ongoing research to identify diagnostic and prognostic biomarkers for OAB like Nerve 
growth factor (NGF), Brain derived nerve factor(BDNF), urinary neurotropins, urinary 
adenosine triphosphate, urinary prostaglandins and cytokines has not yielded any conclusive 
result (Antunes-Lopes et al. 2014;Fry et al. 2014).The studies on the role of these biomarkers 
suffer from serious flaws in design and are under powered (Rachaneni et al. 2013b).The 
prognostic value of these biomarkers has not been demonstrated (Antunes-Lopes, Cruz, Cruz, 
& Sievert 2014). Large scale research into the pathophysiology of normal and abnormal 
bladder function is needed before attempts to identify biomarkers for OAB for non-invasive 
diagnoses. Ultimately, such knowledge will contribute to an improved understanding of the 
bladder function and will pave the way towards new treatments for LUTS.  
7.5 Implications for practice  
Based on the results of the BUS study, I conclude that there is no place for BWT 
measurement in managing women with OAB. History, clinical examination, incontinence 
questionnaires, bladder diaries and urodynamic diagnoses are all part of management 
algorithm of patients with OAB. Hence, the decision making for treatment options may not 
be based on the diagnoses of DO on urodynamics alone.Evidence from clinical studies 
indicate that in women with OAB, an urodynamic observation of DO alone does not impact 
on the outcome of invasive interventions (Groenendijk et al. 2008;Rovner et al. 2011). The 
question arises whether we need to subject our women to invasive diagnostic tests like 
urodynamics and/or BWT scan to diagnose DO if it not going to have an impact on the 
treatment outcome. 
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The pathology behind the symptoms of OAB need to be studied before any attempts to 
identify diagnostic markers. In women with OAB/urgency predominant MUI, randomised 
controlled trials comparing treatment based on urodynamics diagnoses compared to treatment 
based on clinical assessment (history and examination alone) and related health economic 
evaluation for these diagnostic interventions are required to consolidate the role of 
urodynamics in the management of OAB/MUI women. The composite role of patient 
reported outcome measure like ICIQ-OAB SF questionnaires, bladder diaries and changes in 
the quality of life measures need to be established in measuring treatment responses to 
various interventions.Diagnostic accuracy of individual components of office evaluation of 
OAB may be different compared to the composite test accuracy of all the components of 
office evaluation. Studying composite test accuracy of various components in this context 
may be a highly complicated exercise. Further studies need to be planned to look into 
composite test accuracy of office evaluation with or without urodynamics in OAB.  
7.6 Conclusion 
Bladder wall thickness measurement did not discriminate women with DO versus those 
without DO and hence is not an accurate test for diagnosing DO. In the presence of high 
levels of analytical variation for the measurement of BWT, it is unlikely that BWT 
measurement made by transvaginal ultrasound has sufficient reliability and reproducibility to 
be a precise diagnostic test. Women experienced higher levels of embarrassment and a lower 
rate of acceptability with urodynamics compared to the BWT scan procedure. 
7.7 Funding   
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Appendix 1: STARD Checklist for reporting of studies of diagnostic accuracy 
Section and Topic Item 
# 
 On page # 
TITLE/ABSTRACT/ 
KEYWORDS 
1 Identify the article as a study of diagnostic accuracy (recommend MeSH 
heading 'sensitivity and specificity'). 
Title page 
INTRODUCTION 2 State the research questions or study aims, such as estimating diagnostic 
accuracy or comparing accuracy between tests or across participant 
groups. 
29 
METHODS    
Participants 3 The study population: The inclusion and exclusion criteria, setting and 
locations where data were collected. 
48-49 
 4 Participant recruitment: Was recruitment based on presenting symptoms, 
results from previous tests, or the fact that the participants had received the 
index tests or the reference standard? 
49-50 
 5 Participant sampling: Was the study population a consecutive series of 
participants defined by the selection criteria in item 3 and 4? If not, 
specify how participants were further selected. 
49 
 6 Data collection: Was data collection planned before the index test and 
reference standard were performed (prospective study) or after 
(retrospective study)? 
Prospective 
study 
Page 48 
Test methods 7 The reference standard and its rationale. 54 
 8 Technical specifications of material and methods involved including how 
and when measurements were taken, and/or cite references for index tests 
and reference standard. 
Appendix  
6 a(UDS) 
Appendix  
6 b (BUS) 
 9 Definition of and rationale for the units, cut-offs and/or categories of the 
results of the index tests and the reference standard. 
51-54 
Appendix 6  
 10 The number, training and expertise of the persons executing and reading 
the index tests and the reference standard. 
50,72 
Table 6 for 
reproducibi
lity study 
130 
 
 11 Whether or not the readers of the index tests and reference standard were 
blind (masked) to the results of the other test and describe any other 
clinical information available to the readers. 
51 
Statistical methods 12 Methods for calculating or comparing measures of diagnostic accuracy, 
and the statistical methods used to quantify uncertainty (e.g. 95% 
confidence intervals). 
88-89 
 13 Methods for calculating test reproducibility, if done. 66-67 
RESULTS    
Participants 14 When study was performed, including beginning and end dates of 
recruitment. 
58 
 15 Clinical and demographic characteristics of the study population (at least 
information on age, gender, spectrum of presenting symptoms). 
60, Table 4 
 16 The number of participants satisfying the criteria for inclusion who did or 
did not undergo the index tests and/or the reference standard; describe why 
participants failed to undergo either test (a flow diagram is strongly 
recommended). 
61,Figure 8 
Test results 17 Time-interval between the index tests and the reference standard, and any 
treatment administered in between. 
4 wks 
Page 97-
100 
 18 Distribution of severity of disease (define criteria) in those with the target 
condition; other diagnoses in participants without the target condition. 
Tables 12 
and 13 
(UDS), 
Table 6, 
Figure 15 
(BWT) 
 19 A cross tabulation of the results of the index tests (including indeterminate 
and missing results) by the results of the reference standard; for 
continuous results, the distribution of the test results by the results of the 
reference standard. 
Table 14 
 20 Any adverse events from performing the index tests or the reference 
standard. 
UTI in a 
few 
patients 
following 
Urodynami
cs 
Estimates 21 Estimates of diagnostic accuracy and measures of statistical uncertainty 
(e.g. 95% confidence intervals). 
104,  
Tables 
15.16 
 22 How indeterminate results, missing data and outliers of the index tests 
were handled. 
Appendices 
3 and 4 
131 
 
 23 Estimates of variability of diagnostic accuracy between subgroups of 
participants, readers or centers, if done. 
Appendix 5  
 24 Estimates of test reproducibility, if done.      Table 7 
DISCUSSION 25 Discuss the clinical applicability of the study findings. 111 
 
 
 
 
 
 
 
Appendix 2: Study accrual 
 
 
 
 
 
 
0
100
200
300
400
500
600
700
0
10
20
30
40
50
60
Cu
m
ul
at
iv
e 
To
ta
l 
M
on
th
ly
 T
ot
al
 
Monthly Total
Cumulative
132 
 
Appendix 3: Sensitivity analyses 
Figure 3.1: ROC curve excluding those results where the urodynamics test was not blind to the results of the 
ultrasound test  
(16/632 women (3%);   
 
Figure 3.2: ROC curve excluding those results where there was more than four weeks between the tests  
(26/660 women (4%); 
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Figure 3.3: ROC curve incorporating incomplete ultrasound measurements  
(10 observations – average of remaining one or two measurements used); 
 
Figure 3.4: ROC curve using ambulatory urodynamic diagnosis where available 
 (14 participants); 
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Appendix 4: Exploratory analyses 
Figure 4.1: ROC curve including the urgency alone group (as per clinical history; excluding mixed stress/urge 
incontinence group:  
(217 patients) 
 
 
Figure 4.2: ROC curve including the ‘pure’ DO group only (diagnosis of DO/low compliance/DO plus low 
compliance, excluding ‘mixed’ DO - DO with another diagnosis of USI or voiding dysfunction; 
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Figure 4.3: ROC curve including the ‘wet’ DO group only (excluding ‘dry’ DO); 
 
 
Figure 4.4: Box and whisker plot comparing BWT for ‘wet’ and ‘dry’ DO 
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Figure 4.5: ROC curve from exploratory analysis using the trigone measurement alone for BWT 
 
 
Figure 4.6: ROC curve excluding those who had a detrusor pressure rise upon provocation testing ‘provoked DO’ 
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Figure 4.7: ROC curve excluding those who had PVR>30ml upon testing 
 
 
Figure 4.8: ROC curve using the average dome, 1cm left of dome, 1cm right of dome 
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Appendix 5 
Table 5.1: Results of ROC curve analysis in pre-specified subgroupings 
Variable  AUC 95% CI p-value for difference 
between AUCs 
Previous treatment with antimuscarinics =No 0.536 (0.481, 
0.592) 
0.48 
 =Yes 0.501 (0.420, 
0.582) 
 
Clinical history suggested mixed incontinence =No 0.534 (0.460, 
0.608) 
0.73 
 =Yes 0.518 (0.460, 
0.575) 
 
Presence of UTI in the last 12 months =No 0.530 (0.482, 
0.578) 
0.53 
 =Yes 0.586 (0.417, 
0.755) 
 
Patients with voiding difficulties =No 0.533 (0.472, 
0.594) 
0.84 
 =Yes 0.524 (0.454, 
0.593) 
 
Previous incontinence surgery =No 0.526 (0.479, 
0.573) 
0.76 
 =Yes 0.493 (0.294, 
0.693) 
 
BMI <25 0.519 (0.424, 
0.614) 
0.95 
 >=25 0.523 (0.471, 
0.575) 
 
 
 
Table 5.2: Results of univariate analysis exploring factors possibly associated with DO diagnosis 
Variable Data type p-value OR (95%CI) if 
statistically 
important  
Frequencies 
(binary/categorical data) 
ICIQ score (best=0, worst=16) Continuous <0.0001 1.23 (1.15, 1.31)  
BWT, mm Continuous 0.19   
Age, years Continuous 0.66   
Duration of symptoms, years Continuous 0.45   
BMI, kg/m2 Continuous 0.38   
Ethnicity 
(white/black/Asian/other) 
Categorical 0.59   
Vaginal birth=yes Binary 0.64   
Clinical history suggests mixed 
incontinence=yes 
Binary 0.40   
If clinical history suggests 
mixed incontinence, which 
came first 
(stress/urge/unsure/na) 
Categorical 0.66   
Previous treatment with 
antimuscarinics=yes 
Binary 0.001 1.74 (1.24, 2.44) 68% (152/222) DO 
when=yes 
56% (245/441) DO 
when=no 
Previous UTI in last 12 
months=yes 
Binary 0.08 0.60 (0.34, 1.07) 48% (24/50) DO  
when=yes 
61% (363/599) DO 
when=no 
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History of voiding 
difficulties=yes 
Binary 0.16   
Post-menopausal=yes Binary 0.67   
Parity (0/1/2/3/4+) Categorical 0.27   
Previous incontinence 
surgery=yes 
Binary 0.59   
Previous POP surgery=yes Binary 0.32   
 
Table 5.3: Results of multivariable analysis exploring factors possibly associated with DO diagnosis 
Model Significant variables p-value OR (95%CI) if 
significant 
Backward selection (p=0.1 to 
stay in model)  
ICIQ score 
Previous UTI in last 12 months 
<0.0001 
0.04 
1.21 (1.13, 1.29) 
0.51 (0.27, 0.97) 
All variables included ICIQ score 
Previous UTI in last 12 months 
<0.0001 
0.06 
1.21 (1.13, 1.29) 
0.53 (0.27, 1.03) 
All variables included, 
multiple imputation used for 
missing data 
ICIQ score 
Previous treatment with 
antimuscarinics 
Previous UTI in last 12 months 
<0.0001 
0.02 
 
0.07 
1.23 (1.15, 1.31) 
1.57 (1.09, 2.28) 
 
0.57 (0.31, 1.06) 
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Appendix 6  
6a) BUS Standard Operating Procedure for Scanning  
Clinician Preparation 
The clinician performing the BUS should be different to the clinician performing the UDS, to ensure 
blinding between the two tests. 
If, for any reason, this is not possible the BUS should be performed BEFORE the UDS. 
Patient Preparation 
The patient may be seen in various settings: 
Clinic (patient may need other assessment) 
Scan department (may require renal tract assessment and attends with full bladder) 
Ensure patient empties bladder before assessment of Bladder Wall Thickness (BWT) and Post Void 
Residual (PVR) 
Important to stress need to void as completely as possible 
Machine & Probe Preparation 
Ensure scanner is capable of measurement in millimetres (mm) 
Set to the scanner to the Gynae preset 
Use a Trans-Vaginal probe (not a rectal probe) 
Multifrequency – use between 7 & 9 MHz for optimal image (no lower than 5 MHz) 
Prepare the probe: 
Clean 
Put gel into probe cover, excluding air 
Put gel onto tip of probe 
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Timescales 
The ultrasound scan should ideally be completed in a one-stop clinic with the urodynamics test.  
The two tests should be undertaken by different clinicians to ensure blinding of results. 
If it is not possible to hold one-stop clinics, the ultrasound and urodynamics tests should be 
undertaken no more than 4 weeks apart. 
The second test can be undertaken up to a further 4 weeks after this cut-off (8 weeks in total from the 
first test), but the data collected will be classed as a protocol violation. 
If the patient is happy to have one or both tests re-taken (effectively constituting a second ‘set’ of 
tests), they can do so, as long as they haven’t become ineligible in the interim (i.e. begun medication). 
An interval of more than 4 weeks between the two tests will be designated as breach of protocol and 
no per patient payment will be provided for these patients. 
Ultrasound Assessment 
The patient should be in the supine position (stirrups or pad under pelvis as appropriate) 
The TV probe should be inserted into introitus in longitudinal plane 
Position should then be assessed on screen 
Identify the urethra in sagittal orientation 
Position probe such that the VUJ is close to top of screen 
Ensure image sizing is appropriate for screen, between 5-7cm depth 
Focal zone positioned at region of interest; multiple focal zones if possible to give good definition at 
various levels. 
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PVR and BWT should be measured before any other assessment: 
 
PVR: 
Identify entire bladder in sagittal plane, measure longest AP dimension and then CC dimension 
perpendicular to this 
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Rotate probe through 90° and measure axial dimension 
Most machines are now able to generate volumes automatically (need to select this before starting 
with callipers) 
If not available, use the following to standardize calculations: cranio-caudal (H) x anterior-posterior 
(D) x transverse diameter (W) x 0.5233 (prolate ellipsoid) = PVR volume 
ELIGIBILITY: Proceeding to BWT measurement: 
If PVR <=30mls proceed with BWT measurement.  
If PVR >=30ml, ask patient to re-void 
If after re-void PVR is >30 ml but <100 ml measure the BWT. 
If the PVR is >100 ml exclude patient from BUS 
BWT assessment: 
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Measurement should be obtained in sagittal plane with VUJ on margin of screen (probe may need to 
be introduced slightly further) 
3 x measurements: at the dome, anterior wall and trigone need to be obtained 
The same image should be stored twice; with and without callipers 
Any focal areas of thickening need separate assessment and evaluation 
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It is not always possible to see the anterior wall or trigone well, as many women with bladder  
problems often have irregular bladder outline. If the whole of the bladder is not visible on one image 
(as is preferable), there may be the need to angle anteriorly or posteriorly and measure the trigone or 
anterior wall thickness. Patients with significant cystocoeles may find complete emptying difficult and 
trigone may be difficult to visualise adequately 
It is important to document any additional findings (diverticuli, cystocoeles, focal masses) 
Providing Electronic Images: 
Anonymised electronic images for each patient should be provided, labelled clearly with Study ID as 
the only identifier. These images should be as follows: 
PVR image 1 WITH callipers       
PVR image 1 WITHOUT callipers      
PVR image 2 WITH callipers       
PVR image 2 WITHOUT callipers      
Bladder Wall Thickness image 1 WITH callipers    
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Bladder Wall Thickness image 1 WITHOUT callipers   
Bladder Wall Thickness image 2 (optional) WITH callipers   
Bladder Wall Thickness image 2 (optional) WITHOUT callipers  
For optimal quality these should be sent to Birmingham Clinical Trials Unit on disk or memory stick 
in DICOM format ideally.  
Failing this JPEG images will be accepted. 
If downloadable images are not possible please supply a print out of each image listed above, ensuring 
that the print quality is optimal (what is seen on screen). 
SUMMARY 
Prepare patient (ensure voiding takes place just prior to scan and measure in supine position) 
Prepare machine (use vaginal probe and frequency 7-9 MHz for optimal image) 
USS assessment 
Important to obtain good quality images 
Callipers placed on margin of bladder wall for thickness; within bladder lumen (on wall) for volumes 
Store images with and without callipers for cross-referencing and evaluation  
Measure if PVR is <=30ml, revoid if PVR is >=30ml and measure if PVR is >30 but <100ml, exclude 
if PVR is>100ml. 
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6b) Standard Operating Procedure for Urodynamics 
The urodynamics should be performed with aseptic precautions, counselling and verbal consent and 
according to the Good Urodynamics Practice Guidelines (ref- Schafer). 
The equipment needed for the running of the Urodynamic Clinic include:   
Catheter Pack 
Filling Catheter 
Abdominal and Bladder Pressure Catheters 
Instillagel/Sterile Lubricant Gel 
4x 3 way taps (depending on the type of transducers being used) 
2x Fluid Filled Domes 
1x 500ml bag of Normal Saline used for irrigation 
1x Pump Infusion Set 
1x Set Guard 
2x Giving Sets 
2x 100ml bag Normal Saline to flush the domes 
3x pieces of tape (micropore etc, to attach once catheters inserted; ensuring they stay in place during 
filling) 
1x Pair of Sterile Gloves 
Non-Sterile Gloves 
2x Incontinence Pads (1 used for the floor and 1 for patient to sit on) 
Paper Roll to cover the couch 
Sharps Box 
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Plastic Apron 
Towel or Cover for the patient 
Clean Trolley with Antiseptic Wipes 
Please note: The above items may vary depending on the type and make of equipment used in each 
clinic, supplies used at the trust and also in accordance to infection control and hospital policies. 
Ensure all equipment is set up and the person performing the test has not also undertaken the 
ultrasound scan on the patient. 
Ensure the urodynamics test form is to hand and the patient registration number is entered. 
If, for any reason the test had to be abandoned, note this on the test form. 
Uroflowmetry (Initial Voiding Test) 
The patient is asked to attend clinic with a comfortably full bladder. The patient should be encouraged 
to sit in order to void into the voiding flow/volume transducer funnel mounted under the commode.  
• The patient should be instructed to dispose of any tissues/wipes into the bin/bag provided and 
not into the flow meter. 
• The utmost privacy must be maintained during the test and the patient should be made to feel 
comfortable and relaxed, enabling a usual voided pattern to be established. 
•  The maximum void flow rate and volume should then be recorded.  
• The post void residual volume should then be recorded using a drainage catheter and 
measuring container. 
Filing Cystometry (Catheterisation) 
It is essential that the machine is calibrated, set at zero at atmospheric pressure and a reference level 
for pressures should be established. 
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• Ideally the patient should be in the sitting position for the test. If this is not possible it should 
be recorded on the test form.  A sheet should be provided for covering, maintaining dignity. 
• Under aseptic technique, introduce catheters up through the urethra into the bladder and one 
into the rectum.  
• Prior to filling, ask the patient to cough so that the traces can be observed. The spikes on the 
intravesical and intra-abdominal lines should be identical. Any necessary adjustments should 
be made and the cough repeated. 
• Fill rate should be recorded on the test form, but is recommended as 100ml per minute. 
• Ask the patient to cough every minute to ensure continued subtraction. If the lines slip, then 
stop the filling and rectify the problem. 
• Complete test form with the ml at which the patient reports first, normal and strong desire to 
urinate, pain and volume leaked (if applicable). 
• Total volume in the bladder at end of filling should be recorded. 
• Detail any rise in detrusor pressure with or without urgency.  
• At the end of filling, the large catheter used for filling the bladder is removed. The small 
catheter remains in the bladder to record voiding pressures (if using two separate catheters in 
the bladder).  
Provocation Test (whilst bladder is still filled) 
Whilst the intravesical and intra-abdominal lines are in situ, the patient should stand up on the 
incontinence sheet provided and the provocation tests like running taps, coughing, etc should be 
performed. 
• Complete methods used and observations on the test form. 
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Flow Cystometry (voiding) 
• Allow patient to void into commode, recording peak flow rate, max void pressure and 
residual volume with the pressure lines still in. During this voiding phase, the patient’s 
dignity and privacy must be maintained and staff should leave the room if necessary. 
• Ask the patient to cough pre and post void to ensure adequate subtraction. 
Diagnosis  
On completion of the investigation the results may be explained to the patient and fluid advice should 
be given. 
• Record diagnosis in red section of test form. 
• Any ‘optional’/additional tests undertaken should be noted at the end of the form. 
• If video urodynamics is being done, then it is recorded at the end of the form. 
• If patient is scheduled for ambulatory urodynamics, then please give this information on the 
form. 
Advice for patients 
All women who have undertaken the test should be advised to expect some dysuria for up to 72 hours, 
their fluid intake should be increased during this time. 
The occurrence of systemic symptoms, pyrexia and malaise should be advised as an indication to seek 
medical advice i.e. from their GP. 
A contact number should be provided if problems occur. 
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